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The major research project (Chapter 2) has been subject to several changes due to the 
COVID-19 pandemic. The original proposal stated that data collection would be carried out 
through in-person focus groups. Due to the pandemic this was not feasible and so the method 
of data collection was changed to one-to-one interviews using phone or video call, as detailed 
in the revised proposal (Appendix 2.1, p.101). Due to this change in the study design, the 
process of applying for ethical approval was started later than originally planned. 
Consequently, ethical approval was only granted on 18th January 2021. R&D approval was 
then sought. However, extra measures were in place due to the pandemic and R&D approval 
was received on 25th January. As a result of these delays, recruitment for the project did not 
begin until February 2021. Due to the pandemic, one of the Clinical Nurse Specialists who 
was due to assist with recruitment was not able to help with this, leaving just one Clinical 
Nurse Specialist to carry out recruitment. Following delays with these approvals and 
recruitment, data collection did not begin until March 2021. Consequently, it was not possible 
to carry out some aspects of the project that had been specified in the revised proposal; 
member reflections were carried out with two participants rather than all participants who had 
consented to this, and one indexed interview transcript was checked by one supervisor rather 
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Group psychosocial interventions may provide benefits compared to individual therapy such 
as increased social support for patients and reduced treatment costs for healthcare services. 
However, no systematic review has been published to date focusing solely on psychosocial 
group interventions for wellbeing in Parkinson’s disease (PD). This review therefore aimed to 
synthesise and evaluate this literature. Medline, Embase, PsycINFO and CENTRAL 
databases were searched up to May 2021 for randomised controlled trials of group 
psychosocial interventions for people with PD with outcome measures related to wellbeing. 
Twelve studies were included in the narrative synthesis. All studies were found to be at high 
risk of bias using the RoB2 tool. Group mindfulness-based interventions and group cognitive 
behavioural therapy (CBT) were found to improve multiple wellbeing measures for people 
with PD, with effect sizes ranging from small to large for mindfulness and medium to large 
for CBT. Improvements in quality of life were reported for group psychoeducation and a 
group acceptance and commitment therapy-based intervention. Group counselling and a 
group behavioural intervention were not found to be effective. Findings differed across 
studies, indicating that replication is required before conclusions can be drawn regarding 
effectiveness and safety of group interventions for PD. 
 






Parkinson's disease (PD) is a progressive neurodegenerative condition with both 
motor and non-motor symptoms. Motor symptoms include rigidity, resting tremor and 
bradykinesia, while non-motor symptoms include anxiety, depression, sleep problems and 
cognitive impairments (Prediger et al., 2012). 
Estimates of non-motor symptoms in PD are high. One study from Yamanishi et al. 
(2013) identified point prevalence rates of 55% for anxiety and 56% for depression, with 
41% of patients with PD in their study presenting with both anxiety and depression. PD has 
also been associated with a lowering of health-related quality of life (Karlsen et al., 2000), 
and depression and sleep-related problems have been shown to increase levels of distress in 
this population (Karlsen et al., 1999). Non-motor symptoms of PD do not always respond to 
dopaminergic medication (Chaudhuri et al., 2006), and so other forms of treatment are 
required. 
Some previous reviews have found psychosocial interventions, such as Cognitive 
Behavioural Therapy (CBT), to be effective in treating anxiety and depression in patients 
with PD (Yang et al., 2012; Zhang et al., 2020). Psychosocial interventions such as CBT and 
mindfulness are also recommended in evidence-based guidelines for the treatment of anxiety, 
depression and stress in people with PD (The British Psychological Society, 2021). Other 
reviews have concluded that while therapies such as CBT are likely to be efficacious in 
treating depression in people with PD, there are limitations in the existing evidence base such 
as poor methodological rigour and lack of replication of results (Pontone & Mills, 2021; 
Seppi et al., 2019; Xie et al., 2015). Additionally, a scoping review from Zarotti et al. (2020) 
concluded that existing evidence supports the use of CBT to treat depression and sleep 




regarding CBT and mindfulness-based interventions for improving anxiety and quality of life 
in this population. A similar conclusion regarding psychosocial interventions for anxiety was 
reached in a comprehensive review from Chandler et al. (2019).  
In non-neurological populations, group interventions have been found to be effective 
in treating conditions such as depression (Moore et al., 2017). Additionally, it has been 
argued that group interventions are more cost effective than individual treatments (Brown et 
al., 2011). Group formats may also provide other benefits to participants (van der Heijden et 
al., 2017), such as a feeling of social cohesion that has been reported in some group 
interventions for PD (Fitzpatrick et al., 2010). 
While some existing meta-analyses such as Zhang et al. (2020) and scoping reviews 
such as Zarotti et al. (2020) included a small number of group intervention studies, no 
systematic review has been published to date focusing solely on psychosocial group 
interventions for a PD population. This review therefore aimed to synthesise and evaluate the 
existing literature on psychosocial group interventions aimed at improving wellbeing for 
people with PD. Van der Heijden et al. (2017) report high psychological wellbeing as a state 
of “feeling happy, capable, well-supported, and satisfied with life”. 
Cognitive rehabilitation studies were not included in this review as these studies target 
cognitive processes, and resulting improvements in cognition may then have an indirect 
impact on wellbeing. The mechanisms of change in cognitive rehabilitation studies may 








This review aimed to answer the following research question: what is the 
effectiveness of group interventions for people with PD aimed at improving psychosocial 
outcomes related to wellbeing? 
 
Methods 
Protocol and Registration 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; 
Page et al., 2021) guidelines were followed when writing this report. The protocol for this 
review was registered on Open Science Framework (OSF), DOI: https://osf.io/3dukz 
 
Types of Studies 
Randomised controlled trials (RCTs) were included in the review with any type of 
control condition such as no intervention, waitlist and active controls. All other study designs 
were excluded. Reports were required to be available in English language. 
 
Population 
People aged 18 or over with a diagnosis of PD. Samples with comorbid dementia 
were not included. Studies with mixed samples which included some participants with PD 






Any psychosocial group intervention using any therapeutic or psychoeducational 
model. Group interventions were defined as interventions conducted in groups of three or 
more attendees who are not related. If mixed interventions were used (e.g. combined 
psychoeducation and exercise interventions), at least 50% of the intervention must be 
psychosocial in nature and delivered in a group format. Pharmacological and brain 
stimulation intervention studies were not eligible, nor were studies with mixed 
pharmacological/brain stimulation and psychosocial interventions. Participants in treatment 
or control conditions of eligible studies could have been on pharmacological treatment as part 
of usual care, however (e.g. antidepressant medication prescribed outside the study).  
As outlined in the introduction, it was decided in advance that treatments dominated 




Studies must have had a psychosocial outcome related to wellbeing as either the 
primary or secondary outcome. Appropriate psychosocial outcomes included quality of life, 
mood, distress, depression, anxiety, stress, wellbeing, life satisfaction, apathy, coping, 
adjustment and happiness. Studies in which only motor symptoms or a cognitive outcome 
were measured were not eligible for inclusion. To be eligible for inclusion outcome measures 
must use a published instrument pre and post intervention. The principal summary effect 






Searches were conducted from database inception up to 25.05.21 using the search 
strategies detailed in Appendix 1.2, p.95. RCT filters were used to refine searches in Ovid 
Medline and Embase (Wolters Kluwer Health Learning Research & Practice, 2021) and the 
search terms used to identify relevant psychosocial interventions were developed based on 
those used in van der Heijden et al. (2017). The final search strategy was reviewed by author 
BC and a librarian from the University of Glasgow. The following electronic databases were 
searched: Medline (via Ovid), Embase (via Ovid), PsycINFO (via EBSCOhost) and the 
CENTRAL database (via the Cochrane Library). Sensitivity checks were completed using 
previously identified relevant studies. Hand searches were then conducted of reference lists 
of eligible papers. 
 
Screening  
Duplicates were removed using EndNote software. The titles and abstracts of 
remaining search results were screened by author JW using an eligibility checklist developed 
for this review (see OSF registration for details). If papers appeared to meet eligibility criteria 
or where this was unclear, the full text was screened to determine eligibility for inclusion. 
Author TC independently screened 100 search results at the title and abstract stage and 20 
papers at the full text stage. Any discrepancies between author decisions were resolved 







Data Extraction and Synthesis 
Data were extracted from included studies by author JW using a modified version of 
the Cochrane data extraction template. Authors were contacted by email where there was 
insufficient information to make a decision regarding eligibility. Data extracted included: 
participant characteristics, inclusion and exclusion criteria, recruitment, randomisation 
procedure, drop-out, intervention type and format, control group, outcome measures, 
statistical methods and results for relevant outcomes. Five data extraction forms were 
checked for accuracy by author TC. Data were synthesised by intervention type using a 
narrative synthesis method with results summarised in text and tables. 
 
Quality Ratings 
The Cochrane risk of bias tool for randomized trials (RoB2; Sterne et al., 2019) was 
used to rate the methodological quality of included studies. Where relevant, published 
protocols and trial registry records were sought to supplement information in the published 
articles when conducting the ratings. Risk of bias ratings were completed for the primary 
psychosocial outcome of each paper. Where the primary outcome was not specified or where 
there were multiple primary psychosocial outcomes, measures of depression were used for 
the ratings (as depression and quality of life were the most common outcomes across 
included studies). All included studies were rated by author JW and five papers were also 
rated independently by author TC. Any discrepancies between author ratings were resolved 







Results of the Search 
A total of 2,159 studies were identified through database searches. Following removal 
of duplicates, 1,710 studies remained. Three further studies were identified through hand 
searches of reference lists. Title and abstract screening resulted in 1,671 studies being 
excluded. Following full text screening of the remaining 42 papers, 12 were included in the 
review. A PRISMA flow diagram detailing the screening process can be seen in Figure 1. 
The authors agreed on 98% of decisions at the title and abstract stage (Cohen’s k=0.79) and 
95% at the full text stage (Cohen’s k=0.83). 
Two studies which were considered for inclusion (Pickut et al., 2015; Sproesser et al., 
2010) were excluded as authors were contacted regarding group size and no response was 
received. One study by Flores Alves Dos Santos et al. (2017) was considered for inclusion 
however it was decided that this paper was too conceptually different from other studies 
included in the review as it involved a psychoeducation intervention specifically designed for 











Characteristics of included studies are detailed in Table 1. None of the included 
studies appeared to have overlapping samples. Only four studies used active control 
conditions, while eight studies included wait-list or usual care control conditions. Active 
control conditions comprised education sessions (Ayromlou et al., 2020; Hadinia et al., 
2017), group physical therapy (Ghielen et al., 2017) and a “nonspecific” psychological 
intervention which involved education, group discussion, breathing exercises, brief relaxation 
imagery practices and physical exercises (Mohr et al., 1996). One paper (Troeung et al., 
2014) included both a randomised and non-randomised sample. For the purposes of this 
review, only results for the randomised sample are included. 
Six studies did not include a follow-up period. One included a 6-week follow-up 
(Murdoch et al., 2020), three included a 3-month follow-up (Bogosian et al., 2021; Chlond et 
al., 2016; Ghielen et al., 2017), and two a 6-month follow-up (Advocat et al., 2016; Troeung 
et al., 2014). Separate follow-up data for control conditions was only available in Chlond et 
al. (2016) and Ghielen et al. (2017) as wait-list groups had received interventions prior to 
follow-up measurements in all other studies. 
The most common wellbeing outcomes were quality of life, depression, anxiety and 
stress. Each of these outcomes is summarised below. A small number of other relevant 





























C: usual care 











I: 20 male, 
15 female 
C: 15 male, 
14 female 
I: 65.54 (8.94) 















I: 6 weekly 2-
hr sessions 









I: 16 female 
C: 17 
female 
I: 62.8 (7.6) 
C: 63.7 (8.6) 
Aged 18-75, fluent in 
English, able to attend 
≥4 sessions, living in 
the community, 
disability congruent 












I: 8 weekly 2-
hr sessions 
over 8 weeks, 
plus one 7-hr 
retreat day 








QoL: PDQ-39 I: 14 male, 6 
female 
C: 13 male, 
7 female 
I: 67.3 (6.39) 
C: 68.60 (7.32) 
PD diagnosis, H&Y 
stage 1-3, stabilised 
on PD medication for 
6 months, MMSE 
score 17-30, 
commitment to 
participate in sessions 
and home practices. 
Focal neurologic deficit, 
brain imaging 
suggestive of lesions, 
medical conditions that 
would impact quality of 





















I: 13 female 
C: 17 
female 
I: 59.50 (11.12) 
C: 62.23 (8.96) 
PD diagnosis, home 
computer & internet 
access, fluent in 
English, stabilised on 
PD medication, 
antidepressants or 
anxiolytics (if taken) 








participation in other 
psychological therapies, 
prior formal training in 


















Inclusion criteria Exclusion criteria 
Chlond et 
al. (2016) 




C: usual care 
I: 8 90-min 
weekly 















I: 22 male, 
16 female 
C: 19 male, 
10 female 
I: 63.2 (10.6) 
C: 66.2 (10.3) 
Idiopathic PD 
diagnosis. 
MMSE score ≤24, 
clinically relevant 
psychosis or depression. 
Ghielen et 
al. (2017) 







C: group physical 
therapy 
I: 12 1-hr 
twice weekly 
sessions for 6 
weeks 
C: 12 1-hr 
twice weekly 
sessions for 6 
weeks 
I: 19 










I: 59.6 (9.7) 
C: 66.6 (8.4) 
Idiopathic PD 
diagnosis, one or 
more wearing-off 
symptoms, BAI score 
≥26. 











I: group Cognitive 
Behaviour 
Therapy (CBT) 
C: group Health 
Enhancement 
Program (HEP) 
I: 9 2-hr 
weekly 
sessions for 9 
weeks 
C: 9 2-hr 
weekly 







Stress: BELA & 
FKK 
I: 4 female 
C: 3 female 
I: 65 (8.7) 
C: 67 (11) 
PD diagnosis. Severe dementia, 
physical impairment, 










I: 20 sessions 
for 10 weeks 













I: 5 female 
C: 9 female 
I: 63.6 (7.27) 
C: 60.4 (6.65) 
Idiopathic PD 
diagnosis, willingness 
to participate in 
sessions. 
DSM-III-R diagnosis of 
major depression, 
dementia or other 
psychiatric disorder, 
history of alcohol abuse 





I: group Strength, 
Hope and 
Resourcefulness 
I: 6 weekly 2-









I: 7 male, 8 
female 
I: 65.53 (9.11) 
C: 67.37 (9.8) 
PD diagnosed within 
last 5 years, capacity 
to provide consent. 
Psychotic symptoms, 

















Inclusion criteria Exclusion criteria 
Program for 
people with PD 
(SHARP-PWP) 
C: wait-list 
C: N/A Anxiety: BAI 
Wellbeing: MHC-
SF 
C: 6 male, 
10 female 


















15 & DASS-D 










diagnosis, age 18-90, 
provided written 
consent, able to 
















I: 8 weekly 2-
hr sessions 









I: 14 male, 
19 female 
C: 9 male, 
21 female 
I: <60 = 6, 60-
69 = 17, ≥70 = 
14 
C: <60 = 3, 60-
69 = 21, ≥70 = 6 
H&Y stage 1-3, 
regular outpatient 
hospital visits, doctor 













I: group CBT 
C: wait-list 



















this review  




≥6 months since PD 
diagnosis, DSM-IV-
TR diagnosis of at 
least one depressive 
and/or anxiety 
disorder, medications 
stabilised for 3 
months. 





assessed by MINI, 
MINI suicidality score 
>17. 
Note. Abbreviations: I: Intervention; C: Control; HrQoL: Health-related Quality of Life; QoL: Quality of Life; SD: Standard Deviation. Measures: BAI: Beck Anxiety Inventory; BDI: Beck 
Depression Inventory; BELA: Belastungsfragebogen für Parkinsonpatienten (Burden Questionnaire for Patients with Parkinson’s disease); DASS-A: Depression Anxiety and Stress Scale-
Anxiety; DASS-D: Depression Anxiety and Stress Scale-Depression; DASS-S: Depression Anxiety and Stress Scale-Stress; EQ-5D: Euroqol-5D; FKK: Fragebogen zur krankheitsbezogenen 
Kommunikation (Questionnaire for Disease-Related Communication); FKV-LIS-SE: Freiburg Coping with Disease Questionnaire; GAI: Geriatric Anxiety Inventory; GDS: Geriatric 
Depression Scale; GDS-15: Geriatric Depression Scale-Short Form; HADS: Hospital Anxiety and Depression Scale; H&Y: Hoehn & Yahr stage; MHC-SF: Mental Health Continuum–Short 
Form; MINI: Mini International Neuropsychiatric Interview; MMSE: Mini-Mental State Examination; PDQ8: Parkinson’s Disease Questionnaire Short Form; PDQ-39: Parkinson’s Disease 
Questionnaire; PDQL: Parkinson's Disease Quality of Life Questionnaire; PHQ9: Patient Health Questionnaire; SDS: Self-rating Depression Scale; STAI: State Trait Anxiety Inventory;  TICS-
M: Modified Telephone Interview for Cognitive Status; UPDRS: Unified Parkinson’s Disease Rating Scale. 
a Number of participants per group not reported but authors confirmed group size ≥3. 




Risk of Bias 
All included studies were found to be at high risk of bias in at least one of the five 
RoB2 domains, resulting in all twelve papers receiving high overall risk of bias ratings (Table 
2).  
Potential bias arising from the randomisation process was most frequently due to 
unclear reporting on allocation sequence concealment prior to group assignment. Bias due to 
deviations from intended interventions tended to be low. However, intention to treat analysis 
was not used in Hadinia et al. (2017), which may increase the risk of bias in this domain. 
Several of the included studies reported problems with drop-out rates, potentially leading to 
bias due to missing outcome data. 
Eleven of the twelve included studies were rated as high risk of bias in measurement 
of the outcome. Appropriate outcome measures were used in all studies; however, outcome 
measures were often self-report. As wait-list or usual care control groups were utilised in 
eight studies, blinding of participants to group assignment was not possible and so knowledge 
of group assignment may have impacted self-reported outcomes. Three of the four studies 
with active control conditions did not specify whether participants were blinded to group 
assignment and so may also have been at risk of potential bias in outcome measurement. 
Pre-specified analysis plans were not available for most of the included studies, 
making it difficult to determine bias in selection of the reported result. Consistent with RoB2 
guidance, these studies were given ratings of “some concerns”. One study (Ghielen et al., 
2017) employed an analysis method which adjusted for baseline characteristics however this 
was not specified in their protocol analysis plans. The protocol also stated that missing values 





Risk of Bias Within Studies 
Study Bias arising from the 
randomisation process 
Bias due to deviations 
from intended 
interventions (effect of 
assignment to 
intervention) 
Bias due to missing 
outcome data 
Bias in measurement 
of the outcome 
Bias in selection of 
the reported result 
Overall risk of bias 
A’Campo et al. (2010) Low Low Some concerns High Some concerns High 
Advocat et al. (2016) Low Low Some concerns High Low High 
Ayromlou et al. (2020) Some concerns Low Low High Some concerns High 
Bogosian et al. (2021) Low Low Some concerns High Low High 
Chlond et al. (2016) Some concerns Low Some concerns High Some concerns High 
Ghielen et al. (2017) Low Low Some concerns High High High 
Hadinia et al. (2017) Some concerns High Some concerns Low Some concerns High 
Mohr et al. (1996) Some concerns Low Low High Some concerns High 
Murdoch et al. (2020) Some concerns Low Some concerns High Some concerns High 
Rodgers et al. (2019) Some concerns Low Some concerns High Low High 
Son & Choi (2018) Some concerns Low Low High Some concerns High 





Quality of Life 
Ten papers included quality of life outcomes. Relevant results are displayed in Table 
3 and grouped by intervention type. Eight studies used the Parkinson’s Disease Questionnaire 
summary index (PDQ-39-SI), one used the Parkinson’s Disease Questionnaire Short Form 
(PDQ-8) and one the Parkinson’s Disease Quality of Life Questionnaire (PDQL). 
 
Mindfulness 
 Ayromlou et al. (2020) found a small to medium improvement in the PDQ-39-SI 
following intervention but not in the active control group. Similarly, Son and Choi (2018) 
found significantly higher PDQL post-intervention scores in their intervention condition 
compared to the control group (effect size not reported). In contrast, Advocat et al. (2016) 
found no significant differences in the PDQ-39-SI between their intervention and control 
conditions, and Rodgers et al. (2019) found improvements in the PDQ-39-SI over time in 
both intervention and control conditions, with a medium effect size. 
 
CBT 
 Hadinia et al. (2017) found a significant improvement in the PDQ-39-SI in their group 
CBT condition compared to an active control, with a medium to large effect size. This study 
had only one RoB2 domain at low risk of bias. Troeung et al. (2014) did not report PDQ-39 







 Chlond et al. (2016) found improved PDQ-39-SI following the Patient Education 
Program Parkinson (PEPP) and at a 3-month follow-up compared to the control condition 
(effect size not reported). These authors also found that Euroqol-5D (EQ-5D) visual analogue 
scales improved in the intervention group and decreased in the control group post-
intervention (p=0.003). However, these changes were not maintained at follow-up and no 
between-group differences were found on the EQ-5D index. This paper had only one RoB2 
domain at low risk of bias. A’Campo et al. (2010) did not find a significant difference in the 
PDQ-39-SI between the PEPP and control groups. 
 
ACT-Based Intervention 
 Ghielen et al. (2017) was at highest risk of bias of the included studies, with two 
RoB2 domains rated as high. They did not report the PDQ-39-SI and so results from the 
emotional wellbeing subscale are considered here. Large improvements in the emotional 
wellbeing subscale were found post-intervention and at 3-month follow-up for the 
intervention group compared to the control. 
 
Counselling 
Only one RoB2 domain was rated as low risk of bias in Murdoch et al. (2020). Large 






Quality of Life Scores in Intervention and Control Groups 
Intervention 
type 































-0.54 (95% CI:  
-3.41 to 2.32) 
n=24 
26.8 (17.5) 




-1.53 (95% CI:  
-3.64 to 0.57) 
n=33 
Paired t-tests showed that within-group change 
from baseline was non-significant and there 
was no difference between the intervention and 














Within groups t-tests revealed a significant 
difference between baseline and post-
intervention scores in the intervention group 
(p<0.001, delta=-2.05) but not in the control 














Generalised linear models revealed a main 
effect of time (F[1,48]=7.78, p=0.008, Cohen’s 
d=0.53). The main effect of group 
(F[1,48]=2.92, p=0.094, Cohen’s d=0.32) and 
group x time interaction (F[1,48]=0.50, 
p=0.482, ηp2=0.01) were non-significant. 
Mindfulness Son & 
Choi 
(2018) 








Between-groups comparisons revealed a 
significant difference in post-test scores 
between intervention and control groups 
















A MANOVA using change scores showed a 
significant difference between intervention and 




PDQ-39 PDQ-39 scores not 
reported for the 
randomised sample 












































Between-groups t-tests on the change scores 
were non-significant following Bonferroni 
corrections (p=0.015, mean between-group 
difference in change scores=4.86, 95% CI: 0.98 
to 8.73). 












Comparisons using the general linear model 
showed a significant decrease in scores in the 
intervention group compared to the control 
group post-intervention and at 3-month follow-





















Linear mixed model analyses corrected for 
baseline differences revealed a significant 
improvement in scores on the emotional 
wellbeing subscale for the intervention group 
compared with the control group at both post-
intervention and 3-month follow-up (Overall 
treatment effect: β=-10.89, p=0.009, 95% CI: 




PDQ-8 Scale mean: 1.93 
(0.67) 
n=15 
Scale mean: 1.73 
(0.64) 
n=15 
Scale mean: 1.63 
(0.55) 
n=16 
Scale mean: 1.52 
(0.47) 
n=16 
A 2x2 ANOVA compared scale means in the 
groups across time. A significant main effect of 
time was found (F[1,29]=5.98, ηp2=0.17, 
p<0.05). The main effect of group 
(F[1,29]=1.63, ηp2=0.05) and group x time 
interaction (F[1,29]=0.69, ηp2=0.02) were non-
significant. 






Ten studies included depression outcomes and results are displayed in Table 4. Scales 
used to measure depression varied substantially among the included studies. 
 
Mindfulness 
 Son and Choi (2018) reported lower post-test scores on the Geriatric Depression Scale 
(GDS) in the intervention group compared to the control group (effect sizes not reported). 
Rodgers et al. (2019) found no impact of their intervention on their primary outcome 
measure, the Geriatric Depression Scale-Short Form (GDS-15), compared to the control. 
However, they did find a large significant improvement in scores on a secondary outcome 
measure, the Depression Anxiety and Stress Scale-Depression (DASS-D), for the intervention 
group (interaction effect: p<0.001). Bogosian et al. (2021) found changes on the Hospital 
Anxiety and Depression Scale (HADS) over time in both their intervention and control 
groups, with a medium effect size. One study (Advocat et al., 2016) actually found a small 
increase in DASS-D scores over time in the intervention group. Both Bogosian et al. (2021) 




 Troeung et al. (2014) report decreased DASS-D scores in the intervention group 






No significant differences in scores were found between intervention and control 
groups on the Self-rating Depression Scale (SDS; A’Campo et al., 2010) or the HADS 
(Chlond et al., 2016). 
 
ACT-Based Intervention 
No significant differences in Beck Depression Inventory (BDI) scores were found 
between intervention and control groups (Ghielen et al., 2017). 
 
Counselling 
No significant differences were found in Patient Health Questionnaire (PHQ-9) scores 
between intervention and control groups (Murdoch et al., 2020). 
 
Behavioural Intervention 
BDI scores were reduced post-intervention for both intervention and control groups 





Depression Symptoms/Scores in Intervention and Control Groups 
Intervention 
type 
























DASS-D 4.50 (5.22) 








n not reported for 
baseline means 
Change from 
baseline: 1.06 (95% 
CI: -0.84 to 2.97) 
n=33 
t-tests showed a significant increase in symptoms 
over time in the intervention group (exact p value 
not reported). No between-group differences were 












A 2(group: intervention, control) x4(time: 
baseline, mid-intervention, post-intervention, 
follow-up) mixed ANOVA revealed a significant 
main effect of time (F[2.61,151.43]=5.49, 
p=0.002, ηp2=0.086). Main effect of group 
(F[1,58]=1.16 p=0.287, ηp2=0.020) 
and interaction effect (F[2.61,151.43]=2.08, 












Generalised linear models were conducted. The 
group x time interaction (F[1,50]=2.65, p=0.110, 
ηp2=0.05), main effects of time (F[1,50]=0.71, 
p=0.405, Cohen’s d=0.16) and group 
(F[1,50]=1.93, p=0.171, Cohen’s d=0.26) were 
all non-significant. 
Mindfulness Son & 
Choi 
(2018) 








Between-groups comparisons found a significant 
difference in post-test scores between 
intervention and control groups (t=-3.78, 












The change in scores across time for intervention 
and control groups were compared. The time x 
group interaction was non-significant 
(F[1,12]=3.62, p=0.080, Cohen’s d=0.94). Main 










































Bonferroni adjusted t-tests on change scores in 
the two groups were non-significant (p=0.050, 
mean between-group difference in change 
scores=3.51, 95% CI: -0.00 to 7.02). 
Psychoeducation Chlond et 
al. (2016) 
HADS 7.5 (3.8) 
n=38 
Data not reported 7.1 (3.1) 
n=29 
Data not reported Comparisons of intervention and control groups 















Linear mixed model analyses corrected for 
baseline differences showed posttreatment effects 
and overall treatment effects (including follow-
up) were non-significant (Overall treatment 
















A 2x2 ANOVA compared scale means in the 
groups across time. Main effects of time 
(F[1,29]=1.81, ηp2=0.06) and group 
(F[1,29]=0.13, ηp2=0.00) were non-significant, as 














A two-way ANOVA revealed a main effect of 
time (F[1,39]=10.6, p<0.002, effect size not 
reported). No between-group differences were 
found (test statistics not reported). 
Note. BDI: Beck Depression Inventory; DASS-D: Depression Anxiety and Stress Scale-Depression; GDS: Geriatric Depression Scale; GDS-15: Geriatric Depression Scale-Short Form; HADS: 
Hospital Anxiety and Depression Scale; PHQ-9: Patient Health Questionnaire, SDS: Self-rating Depression Scale. 






Eight studies included anxiety outcomes and results are summarised in Table 5. 




Only one study found improvements in anxiety symptoms (measured by the State 
Trait Anxiety Inventory [STAI]) post-intervention in the intervention group compared to the 
control (Son & Choi, 2018). One study found improvements in HADS scores over time in 
both intervention and control groups, with a large effect (Bogosian et al., 2021). Two studies 
found no effect of mindfulness-based interventions compared to controls on anxiety 
symptoms measured by the DASS-Anxiety (DASS-A; Advocat et al., 2016; Rodgers et al., 
2019) and Geriatric Anxiety Inventory (GAI; Rodgers et al., 2019).  
 
CBT 
 Troeung et al. (2014) found a large reduction in DASS-A scores in the intervention 
group compared to the control. 
 
Psychoeducation 
 Chlond et al. (2016) found no difference over time in HADS anxiety scores between 






 Ghielen et al. (2017) found no significant differences in Beck Anxiety Inventory 
(BAI) scores between intervention and control groups. 
 
Counselling 
No significant differences were found over time in BAI scores between intervention 






Anxiety Symptoms/Scores in Intervention and Control Groups 
Intervention 
type 
























DASS-A 7.58 (4.79) 












-0.63 (95% CI:  
-2.92 to 1.67) 
n=33 
t-tests showed no difference in change scores 












A 2(group: intervention, control) x4(time: 
baseline, mid-intervention, post-intervention, 
follow-up) mixed ANOVA revealed a 
significant main effect of time 
(F[3,174]=12.61, p<0.001, ηp2=0.179). Main 
effect of group (F[1,58]=0.98, p=0.325, 
ηp2=0.017) and interaction effect 













Generalised linear models were conducted. 
There was no significant group x time 
interaction (F[1,50]=3.53, p=0.066, 
ηp2=0.07), and no main effect of time 
(F[1,50]=0.06, p=0.816, Cohen’s d=0.04) or 
group (F[1,50]=0.003, p=0.954, Cohen’s 
d=0.01). 













Between-groups comparisons found a 
significant difference between the post-test 
scores of the intervention and control groups 












The change in scores across time for the 
intervention and control group were 
compared. The time x group interaction was 
significant (F[1,12]=9.50, p=0.007, Cohen’s 


























Results for group differences 
Psychoeducation Chlond et 
al. (2016) 
HADS 6.9 (3.5) 
n=38 
Data not reported 7.3 (3.8) 
n=29 
Data not reported No significant between-group differences 















Linear mixed model analyses corrected for 
baseline differences revealed non-significant 
posttreatment effects and overall treatment 
effects (Overall treatment effect: β=-3.29, 
















The main effects of time (F[1,29]=0.58, 
ηp2=0.02) and group (F[1,29]=0.61, ηp2=0.02) 
were non-significant, as was the group x time 
interaction (F[1,29]=0.23, ηp2=0.00). 
Note. BAI: Beck Anxiety Inventory; DASS-A: Depression Anxiety and Stress Scale-Anxiety; GAI: Geriatric Anxiety Inventory; HADS: Hospital Anxiety and Depression Scale; STAI: State 
Trait Anxiety Inventory. 











 Rodgers et al. (2019) did not report results for the DASS stress subscale (DASS-S). 
Another study, with one of the lowest risk of bias ratings across domains, found a small but 
significant increase in DASS-S scores at post-intervention for the intervention group 
compared to the control group (Advocat et al., 2016). 
 
CBT 
 Troeung et al. (2014) did not find a significant impact of group CBT on DASS-S 
scores. However, Hadinia et al. (2017) found a significant improvement in stress measured by 
both the BELA (Belastungsfragebogen für Parkinsonpatienten [Burden Questionnaire for 
Patients with Parkinson’s disease]) and FKK (Fragebogen zur krankheitsbezogenen 
Kommunikation [Questionnaire for Disease-Related Communication], p=0.04) in the 
intervention group compared to the control. Effect sizes were large and medium respectively, 






Stress Symptoms/Scores in Intervention and Control Groups 
Intervention 
type 
























DASS-S 8.78 (6.35) 












-1.63 (95% CI: -3.68 
to 0.43) 
n=33 
t-tests showed a significant increase in 
stress over time in the intervention group 





DASS-S DASS-S results not 
reported 












A MANOVA found a significant difference 













Comparisons of the change in scores over 
time for the intervention and control group 
were non-significant (p=0.169, Cohen’s 
d=0.47). 
Note. BELA: Belastungsfragebogen für Parkinsonpatienten (Burden Questionnaire for Patients with Parkinson’s disease); DASS-S: Depression Anxiety and Stress Scale-Stress. 







Summary of Findings 
The findings indicate the potential effectiveness of group mindfulness-based 
interventions and group CBT on multiple measures of wellbeing. However, these impacts 
were not consistent across studies, and one mindfulness-based intervention appeared to have 
a negative impact on some wellbeing measures. The mixed nature of mindfulness results may 
be attributable to differences in the content of interventions, which varied substantially across 
studies. Additionally, a range of measures were used to assess outcomes, which may further 
contribute to the heterogeneity of results. Moreover, all studies included in the review were 
identified as high risk of bias, indicating that findings should be interpreted with caution. 
The impact of the PEPP psychoeducation intervention and ACT-based BEWARE 
programme on wellbeing outcomes were limited to measures of quality of life. The SHARP-
PWP group counselling intervention and the group behavioural intervention were not found 
to be more effective than control conditions, suggesting that these interventions may be less 
effective for people with PD. 
The current review’s positive findings regarding group CBT mirror those of previous 
reviews of mixed individual and group CBT approaches (Yang et al., 2012; Zhang et al., 
2020). A scoping review from Zarotti et al. (2020) into psychological interventions for PD 
concluded that there is contrasting evidence regarding the impact of CBT on anxiety and 
quality of life. In comparison, the current review found positive impacts of group CBT on 
these outcomes. However, only two group CBT studies were included in the current 
synthesis, highlighting the need for further research into group CBT. The mixed findings 
regarding group mindfulness interventions identified in the current review are similar to those 




although they did not include the psychoeducation studies included in the current review. The 
reason for this is unclear, as they did include an uncontrolled study of the PEPP. In contrast 
to their predominantly negative findings regarding psychoeducation, the current review 
reported improvements in quality of life measures following group psychoeducation in one 
study utilising the PEPP. The current review builds on this previous research and provides a 
unique focus on group psychosocial interventions for people with PD. 
 
Study Limitations and Risk of Bias 
Eleven of the twelve studies included in the review were rated as at high risk of bias 
in measurement of the outcome. This resulted from a combination of the use of self-report 
measures and either lack of or unclear blinding of participants to their group assignment. 
Consequently, awareness of group assignment may have impacted on self-reported outcomes 
following intervention. Another limitation was the small number of studies utilising active 
control conditions. Only four of the included studies employed active control conditions and 
only one of these specified that participants were not informed of their group allocation. 
Where wait-list or usual care controls were used, blinding was not possible. The use of these 
types of control conditions also makes it challenging to identify intervention specific effects 
as opposed to placebo effects or the impacts of informal social support in a group setting 
which have been reported by participants in studies such as Fitzpatrick et al. (2010). 
Sample sizes were small in many of the included studies. Some papers such as 
Rodgers et al. (2019) were pilot studies in which small sample sizes were expected, while 
others such as Troeung et al. (2014) reported recruitment difficulties leading to smaller 




analyses, which may have impacted results and limits the conclusions that can be drawn 
regarding intervention effectiveness.  
Several of the included studies also reported high drop-out rates, at times resulting in 
further reductions in the available sample for analysis. Where reasons for dropout and 
outcome data are not available for participants who discontinued interventions, it is difficult 
to determine if dropout was associated with negative impacts of the intervention itself or a 
worsening of symptoms. Consequently, reasons for dropout should be sought and reported 
where possible and efforts should be made to obtain outcome data from all participants when 
appropriate. Given that one study found an increase in depression and stress following 
intervention, recording and reporting of adverse events may be a useful addition to future 
research. This lack of adverse event monitoring has previously been highlighted as a 
limitation of CBT trials with PD populations (Seppi et al., 2019). 
Additionally, there were some issues related to reporting of information. As noted 
above, some authors did not report effect sizes of their findings, or sufficient data to allow a 
reviewer to calculate these. Additionally, separate follow-up data for intervention and control 
groups was only gathered in two studies. Wait-list control conditions where participants 
subsequently receive the intervention can make it difficult to provide longer term follow-up 
data. Finally, most papers included in the review did not include demographic information on 
important characteristics such as ethnicity. 
 
Review Strengths and Limitations 
This review used the Cochrane Handbook for Systematic Reviews of Interventions 




biases and errors in this review by including a second rater at all stages of the review process, 
although it was not feasible to do this for 100% of records at each stage. Extra information on 
included studies was sought from study protocols and registers, and authors were contacted 
where required to clarify information regarding eligibility for review. Another strength of the 
review is the consideration of a wide range of interventions and outcomes, resulting in a 
comprehensive synthesis. 
Statistical synthesis was not used in this review. There was substantial variation in 
outcome measures used in included studies, which made comparisons challenging. This issue 
has also been reported in other reviews on nonpharmacological interventions for people with 
PD (Chandler et al., 2019).  
When rating the risk of bias, ratings of “some concerns” were given to papers where 
information was not reported, such as pre-specified statistical analysis plans. It should be 
noted that analysis plans may exist for these studies but as these were not reported a rating of 
“some concerns” was given, consistent with RoB2 guidance. 
This review only included published RCTs. While this resulted in the inclusion of 
methodologically more robust trials, it may also have led to the exclusion of potentially 
relevant evidence from unpublished studies or studies using other designs. Additionally, only 
studies available in English were included, which may have omitted relevant trials published 
in other languages. It was not feasible to conduct forward citation searching in this review, 
which may have caused relevant papers to be missed. However, the comprehensive search 
strategy returned a large number of results and sensitivity checks of search strategies found 
that no relevant studies known to the authors were omitted. Additionally, backward citation 





Future Recommendations and Conclusions 
The findings of this review suggest that group psychosocial interventions such as 
mindfulness-based interventions and CBT may be efficacious for use in clinical settings for 
people with PD. However, given the small number of RCTs in this area, the small sample 
sizes of included studies and resulting impact on statistical power, the high risk of bias of 
included studies, and the mixed results found for some interventions, further research into 
group interventions for people with PD is required to establish their clinical safety and 
effectiveness. Additionally, the high numbers of dropouts reported in several studies suggest 
that group psychosocial interventions may not be acceptable to some people with PD. 
Therefore, people with PD should be offered choice in psychosocial interventions when 
possible. Future research should aim to address quality issues in the existing literature. 
Suggestions to improve methodological rigour and reduce risk of bias include: conducting 
analyses as intention to treat, monitoring adverse events, utilising active control conditions, 
and blinding participants to group assignment where self-report outcome measures are used. 
The current review demonstrates the promising nature of group psychosocial 
interventions while highlighting the need for further high-quality research. This review builds 
on previous work and provides a unique synthesis of the evidence-base for group 
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Plain Language Summary 
Title: Developing psychological wellbeing support for patients with Parkinson's disease: A 
qualitative study of patients’ preferences and barriers to participation 
Background: Parkinson's disease (PD) is associated with high rates of depression and 
anxiety, for which group talking therapies such as Cognitive Behavioural Therapy (CBT) 
may be an effective treatment. Previous research has found that incorporating the preferences 
of patients into psychological treatment can increase the effectiveness of treatment and 
decrease dropout prior to treatment completion. There is currently limited research into the 
preferences of patients with PD for psychological support and potential barriers to taking part 
in this form of support. 
Aims: The aim of this project was to gain a better understanding of the preferences of 
patients with PD for psychological support, and how barriers to participation can be 
overcome. 
Methods: Patients with PD in one UK health board were invited to take part in the study. To 
take part participants were required to have a diagnosis of PD without dementia, be aged 18 
or over, be fluent in English, have experienced difficulties with mental health, be able to 
consent to taking part, and be able to take part in an interview independently over phone or 
video call. Twelve adults with PD were recruited and one-to-one semi-structured interviews 
were conducted. Interviews covered topics such as content and format of psychological 
support, and barriers to participation. Framework analysis was conducted to identify themes 
in the interview data, and two participants were invited to provide further reflections on 
results to increase credibility. 
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Main findings: Three factors were identified which influence people with PD when 
considering accessing support from psychological services: the perceived need for support, 
choosing whether to engage in support given a need has been identified, and the barriers to 
accessing support. Subthemes highlight the importance of providing support that is flexible, 
realistic and individually tailored to each person’s needs and preferences. Suggestions are 
also provided for overcoming barriers to accessing psychological support for this population 
such as providing information on available services and offering choice.  
Conclusions: Identified barriers to accessing psychological support were found to mirror 
those reported in previous research. The current study expands on previous findings through 
the identification of barriers regarding group psychological support and the impact of the 
Covid-19 pandemic, as well as investigating preferences for the content and format of 
support, and exploring strategies to overcome barriers. The findings demonstrate the 
importance of increasing awareness of psychological services, improving service 
accessibility, and identifying the individual needs of patients with PD when delivering 




Previous research has identified that incorporating the preferences of patients into 
psychological treatment can increase the effectiveness of interventions and decrease dropout 
rates prior to treatment completion. There is currently limited research into the preferences of 
patients with Parkinson’s disease (PD) for psychological support and potential barriers to 
participation. This study therefore aimed to gain a better understanding of the preferences of 
patients with PD for psychological support, and how barriers to participation can be 
overcome. Semi-structured interviews were conducted with 12 people with PD, covering 
topics such as content of psychological support and barriers to participation. Themes from the 
interviews were identified through framework analysis. The resulting framework represents 
the factors influencing people with PD when considering accessing support from 
psychological services. Three interlinked factors were identified: the perceived need for 
support, choosing whether to engage in support given a need has been identified, and the 
barriers to accessing support. These themes are explored and suggestions provided for 
overcoming barriers to accessing psychological support for this population. 
 




Parkinson's disease (PD) is a neurodegenerative disorder characterised by both motor 
symptoms, such as a resting tremor and rigidity, and non-motor symptoms, such as cognitive 
and olfactory problems (Prediger et al., 2012). PD is also associated with high rates of 
depression and anxiety, with one study finding point prevalence rates as high as 55% for 
anxiety and 56% for depression (Yamanishi et al., 2013). 
There are limited available treatments for mood disorders in PD (Chen & Marsh, 
2014). However, Cognitive Behavioural Therapy (CBT) may be effective in reducing 
depression and anxiety symptoms in individuals with PD (Zarotti et al., 2020; Zhang et al., 
2020), and this approach has been recommended in recent evidence-based guidelines for 
psychological interventions for people with PD (The British Psychological Society, 2021). 
There is also some evidence to suggest that group CBT and group mindfulness-based 
interventions may be effective in improving wellbeing in people with PD, as shown in the 
systematic review (Chapter 1). However, results of studies included in the systematic review 
were mixed and some group interventions were not found to be effective. 
Previous research has found that incorporating patient preferences into treatment can 
increase the effectiveness of psychological interventions and decrease dropout prior to 
treatment completion (Swift et al., 2018). These authors found that when patient preference is 
taken into consideration, patients are significantly less likely to end treatment early than 
patients whose preferences are not adhered to, and intervention outcomes are significantly 
more positive. These findings demonstrate the importance of understanding patient 
preferences for treatment. However, at present there is limited research into the preferences 
of people with PD for psychological support.  
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When considering increasing patient engagement and reducing dropout prior to 
treatment completion, it is also important to consider barriers to participation in support. A 
small number of previous studies have investigated barriers to engaging in support for people 
with PD. Dobkin et al. (2013) surveyed individuals with PD and found that issues with 
transport, availability of services and physical impairments were perceived as barriers to 
using mental health services. Practical issues were also reported as a barrier to participation 
in a group exercise intervention study for people with PD (Sajatovic et al., 2017). Study 
participants reported enjoying social aspects of groups but found it difficult to attend sessions 
at fixed times, and problems with transportation and meeting locations made participation 
difficult. 
Another survey study from Troeung et al. (2015) found that younger age and a belief 
that mental health interventions will be effective were significant predictors of uptake of 
mental health care, while stigma was reported as a concern for a small proportion of people 
with PD. A qualitative study from Oehlberg et al. (2008) also found that some participants 
with PD had concerns about engaging in psychotherapy due to stigma, as well as discomfort 
in talking about personal problems to people they did not know, and issues with 
transportation. 
The previous research described above has mainly been quantitative, with a lack of 
scope for further exploration of participant views. Additionally, the one qualitative study 
from Oehlberg et al. (2008) touched on barriers to engaging in psychotherapy but did not 
explore patients' treatment preferences for psychological support. Thus, further research into 




Consequently, this study will aim to form a better understanding of the preferences of 
patients with PD for psychological support, and how barriers to participation can be 
overcome. The results will be used to guide recommendations for psychological services for 
patients with PD. By developing psychological support for patients with PD driven by the 
preferences and experience of patients themselves, it is hoped that patient engagement in 
psychology services will be increased and the effectiveness of support enhanced. 
 
Aims 
The aims of this study were to gain a better understanding of the preferences of 
patients with PD for psychological support, and how barriers to accessing this form of 
support can be overcome.  
 
Research Questions 
1. What are the preferences of patients with PD for the content and format of support 
for psychological wellbeing? 
2. What views and experiences do patients have on the barriers to participation in 
psychological support and how these can be overcome? 
3. What are the opinions of patients on what would be helpful to include in an initial 







This study is reported in accordance with the COnsolidated criteria for REporting 
Qualitative research (COREQ) checklist (Appendix 2.2, p.121; Tong et al., 2007). 
 
Design 
The study employed a qualitative interview design.  
 
Participants and Setting 
Participants were adults with a diagnosis of PD who were registered with the 
movement disorders service in the NHS Ayrshire & Arran health board in Scotland. The 
Neuropsychology service in this region had previously offered a group psychological 
intervention to people with PD but had experienced poor uptake of this, and so this was a 
relevant setting in which to conduct the research. Inclusion criteria required participants to: 
have a clinical diagnosis of idiopathic PD with no concurrent dementia diagnosis; have 
experienced problems with their mental health (as judged by the Clinical Nurse Specialist 
[CNS] who screened case records); be aged ≥18; be fluent in English; have the capacity to 
provide informed consent to take part in the study; be able to contribute independently to the 
interview; and have access to either a phone or device for video call. 
 
Ethical Approval 
Ethical approval (20/WS/0172) was granted by the West of Scotland NHS Research 
Ethics Committee on 18th January 2021 (See Appendix 2.3, p.123 for a copy of approval 
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letter). All participants provided verbal informed consent, which was audio-recorded at the 
start of the interview, and were provided with a copy of the consent form (Appendix 2.4, 
p.129) and information sheet (Appendix 2.5, p.130). 
 
Recruitment 
Participants were recruited through the NHS Ayrshire & Arran health board. To 
identify eligible participants a PD CNS reviewed the files of patients with PD living in the 
health board. Patients who met inclusion criteria were then purposively selected by the CNS 
to receive an invitation letter. The CNS selected a range of eligible patients such that some 
had previously received support from psychological services while others had not, as the 
research team felt it was important to hear the views of both groups. Eligible patients were 
sent an invitation pack by the CNS, containing an information sheet, invitation letter and 
reply slip (Appendix 2.6, p.136), and a pre-addressed and pre-paid envelope. Patients were 
asked to return the reply slip if they were interested in participating and consented to be 
contacted by the lead researcher (JW). Those patients were then contacted by the researcher 
to provide the opportunity to ask questions about the study and to arrange the interview. All 
participants were offered a £5 supermarket voucher as a thank you for their time. 
 
Materials 
The interview schedule (Appendix 2.7, p.138) was developed based on the research 
questions and previous literature. 
The first part of the schedule consisted of demographic and clinical self-report 
questions, adapted from Dobkin et al. (2013). Patients were also asked for their postcode to 
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calculate the Scottish Index of Multiple Deprivation (SIMD). The SIMD is a measure of 
relative deprivation by area and can be expressed as quintiles, where quintile 1 represents the 
most deprived areas. 
The second part of the schedule covered topics such as: content, format and 
practicalities of psychological support, what participants would hope to gain from 
psychological support, barriers to participation and how these could be addressed (Krueger et 
al., 2001; Letourneau et al., 2012; Todd et al., 2013). Participants were also asked their 
opinions on content to include in an invitation letter to be sent to patients in the health board 
providing information about psychological services. A draft of the schedule was reviewed by 
members of the charity Parkinson’s UK and a charity representative. Feedback indicated that 
it would be helpful to provide details of what psychology services do. A paragraph describing 
psychology services was added to the schedule and participants were given the opportunity to 
ask questions about this. 
 
Procedure 
Following the initial call, participants were contacted at the agreed time for the 
interview. Participants took part in interviews from home either by telephone or secure video 
call using Attend Anywhere software provided by NHS Scotland. No others were present 
during the interviews. The interviews were audio-recorded using handheld digital devices and 
field notes were taken by the researcher. Interview schedule questions were supplemented 
with clarifying questions and probes to encourage expansion on provided answers. 
Participants were also asked if they would be willing to participate in member reflections and 
if they consented to being re-contacted for this purpose. Following the interviews, 
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participants were sent an information sheet containing contact details of local NHS clinicians 
and relevant support organisations. No repeat interviews were carried out. 
Following initial analysis of interview data two participants who had consented to 
take part in member reflections were contacted to arrange for a summary of themes, 
conclusions and interpretations (Embi et al., 2004) of their individual interview data to be 
sent by post. Full copies of the interview transcripts were not returned to participants. 
Following receipt of the summaries the researcher then re-contacted these participants by 
phone and asked for their reflections on the findings. 
Following the interviews, the CNS gathered basic data from medical records on 
participant age, gender, diagnosis, years since diagnosis, history of mental health problems, 
whether the patient had previously received mental health support, and whether the patient 
was invited to take part in a psychological wellbeing group previously offered by the local 
NHS service.  
 
Data Analysis 
Audio recordings were transcribed verbatim by the lead researcher as part of the 
familiarisation process. The resulting data was then analysed using framework analysis 
(Ritchie & Spencer, 2002) to identify key themes in the data. Framework analysis is a type of 
thematic analysis that is a grounded and systematic approach to synthesising and interpreting 
qualitative data (Ritchie & Spencer, 2002). It was chosen as the analysis method for the 
current study as it is a thematic approach in which themes can be identified both from the 
data itself and from the original research questions (Rabiee, 2004), and it is regularly used for 
analysing data from semi-structured interviews (Gale et al., 2013).  
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Data were organised and interpreted using the five-step approach proposed by Ritchie 
and Spencer (2002). The first stage involved the researcher familiarising themselves with the 
data by listening to and reading interview transcripts, and noting any initial themes. A 
combined inductive and deductive approach was then taken to construct a thematic 
framework. This was done by identifying themes driven by the interview schedule itself, 
issues expressed by participants, and concepts that were evident from patterns or repetitions 
in discussions with participants. The third stage involved the researcher indexing the 
individual interview transcripts according to the framework, and the fourth involved 
rearranging summaries of the data in Microsoft Excel charts according to theme. The final 
stage involved the researcher analytically studying the charted data to discover patterns and 
explanations, and using these findings to inform recommendations. Coding was carried out 
by the lead researcher. Another member of the research team (BC) reviewed one indexed 
interview transcript and provided reflections on the indexing process and initial themes. The 
aim of incorporating the views of a second researcher was to develop a fuller and deeper 
understanding, in keeping with the goals of ‘crystallisation’ (Madill et al., 2000; Tracy, 
2010). 
Following initial analysis and charting, member reflections were carried out with two 
participants to increase the credibility of the findings and methodological rigour of the study. 
The two participants were sent a summary of themes at the charting stage, with content from 
their individual interviews summarised according to theme. The participants were invited to 
give reflections on the framework themes and content of their initial interview. These 
member reflection interviews were audio recorded, transcribed, indexed and charted, and any 





The sample sizes detailed in previous qualitative interview studies utilizing the 
framework approach have varied substantially, from samples of 6 participants (Hackett & 
Strickland, 2018) through to samples as large as 77 participants (Parkinson et al., 2016). 
However, there often does not appear to be any clear theoretical justification for the choice of 
sample size, and this is a problem that has been reported in the wider field of qualitative 
health research (Vasileiou et al., 2018). The concept of theoretical saturation is used by some 
papers to justify sample size, and saturation has been reported by some researchers early in 
the process of thematic analysis of individual interviews. For example, Guest et al. (2006) 
reported that broad themes became apparent after analysis of just 6 interviews, and Hennink 
et al. (2017) reported discovering 84% of codes by the 6th interview they carried out. 
Additionally, literature on data sufficiency has found that codes can be identified with just 6-
9 participants and 7-10 participants are needed for substantial theme identification, with 
further participants providing increased nuance (Young & Casey, 2019). Given these 
findings, the current study aimed for a sample size of 12 participants to ensure that codes and 
themes could be sufficiently identified. 
 
Reflexivity 
The researcher's theoretical stance is one of contextual constructionism. This 
epistemology posits that the analysis process and subsequent findings are subjective and 
dependent on the context of the participants and researcher, although still grounded in 
participant accounts. The goal of analysis is therefore to develop a richer understanding rather 
than to discover objective 'truths' (Madill et al., 2000). 
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Data collection and analysis were conducted by the lead researcher JW. JW is a 
female, university graduate, Trainee Clinical Psychologist with 2.5 years experience working 
within NHS Ayrshire and Arran. JW did not have contact with participants prior to 
recruitment. Participants were made aware of the researcher’s job title and reasons for 
conducting the research in the participant information sheet. 
Interviews took place in March and April 2021 during the COVID-19 pandemic and 
were consequently conducted by video or phone call. 
A reflective log was kept by JW during the interview, transcription and coding phases 
to provide a reminder of issues not captured in the transcripts (such as contextual 
information) and to support the researcher's reflexivity. Samples of reflections are detailed in 




A total of 40 patients were invited to take part, 14 of whom responded. The first 12 
individuals to reply were invited to participate in the interview, all of whom agreed. The 
length of interviews ranged from 28 to 95 minutes, with a mean duration of 55 minutes. Six 
participants were female and the age range of the sample was 56-74, with a mean age of 67. 
Eight participants were retired, two employed full-time, one employed part-time, and one 
unemployed. The time since PD diagnosis ranged from 1-12 years, with a mean of 5.58 years. 
One participant self-reported a mild impact of PD on their daily life, one mild to moderate, 
seven moderate, one moderate to severe, and two severe. Eleven participants were living in 
owned accommodation and one in rented accommodation. Six participants lived within 
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SIMD quintile 1 areas, one in quintile 2, two in quintile 3, and three in quintile 5. All 
participants were identified by the CNS as having had mental health difficulties and six were 
formally reported as having a history of mental health problems in their medical record. 
Interestingly only nine participants self-reported mental health difficulties during the 
interviews, although the remaining three mentioned some impact of PD or stress on their 
mental health. Eight participants reported having received support for their mental health. 
 
Development of the Framework 
An initial framework consisting of six main themes was used to index interview 
transcripts (Appendix 2.9, p.143), with new subthemes added as they were identified in the 
data. A sample of indexing is provided in Appendix 2.10, p.145. Review of one full indexed 
transcript by a second researcher informed the identification of a new theme which was 
incorporated into the framework. The framework was then condensed to five main themes 
which were used to structure the data during charting. Clarifications and feedback from the 
two member reflections were then incorporated into the charts. The two participants who took 
part in member reflections reported that the summaries sent to them were a good reflection of 
their individual interviews and they advised that the themes made sense and flowed well. The 
member reflections also led to elaboration of topics from the initial interviews, which allowed 
the researcher to develop a deeper understanding of these participants’ experiences and 
opinions. 
The framework was refined during mapping and interpretation stages to the final three 
core themes and fifteen subthemes displayed in Figure 2. All themes and subthemes were 
identified by the eighth interview, consistent with findings from data sufficiency literature 
(Young & Casey, 2019). The final framework represents the factors influencing people with 
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PD when considering accessing support from psychological services. This appears to be 
guided by three interlinked factors: the perceived need for support, choosing whether to 
engage in support given a need has been identified, and the barriers to accessing support. 
Each subtheme is described below, with relevant quotes from participants in italics.  
The interviews produced further data relating to other issues (e.g. the impact of PD, 
personal experiences of support) which were indexed and charted but are not presented in the 










Perceived Need for Support 
Perceived Symptom Severity 
Throughout the interviews it became apparent that a shared criterion for accessing 
support from psychology services related to feeling that symptoms were “severe enough” that 
help is required: “I just realised I’d got to rock bottom and I really needed the help. I think 
you really need to admit to yourself that you need it before you can accept it” (P107). 
The concept of resilience was also raised by a small number of participants who 
reported that they possessed a characteristic of “strength” and therefore did not need to access 
help: “Personally I’m quite strong and so I don’t feel the need” (P102). Curiously, one 
participant who reported this also mentioned having previously sought counselling when 
experiencing difficult personal circumstances. Some participants also voiced an air of 
reluctance in seeking help: “Well you don’t want to admit when you need some help, you 
know, with your thoughts” (P103). 
 
Opinions of Others 
Several participants noted that healthcare professionals identified the need for 
psychological support, at times before the participant themselves:  
When I was diagnosed at first I thought I was OK but people around me and my 
consultant, my doctor said I wasnae handling it so I had to go and see a Psychologist. 
Well I didn’t have to go. I went to her, she helped (P108).  
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The importance of others identifying the need for support was also highlighted by a 
participant who had not previously accessed support: “if I've heard that I definitely need 
some help I would definitely do it yeah” (P111). 
 
Support Network 
Another factor impacting on the perceived need for psychological support was the 
quality and utilisation of participants’ support networks. Two main sources of social support 
were identified. The first was support from family and friends. This was highlighted by some 
participants as a reason that psychological support was not needed: “Personally for me it's 
not really something I would want to do. It would be OK if you didn't have any family or 
anybody to speak to, it would be an ideal situation” (P106). However, it was recognised by 
participants that social support does not completely offset the need for psychological support, 
particularly when symptoms are more severe. Others noted concerns about sharing worries 
with family: “it was really again just about offloading and feeling that I could speak about 
my fears and my concerns for the future without my family having to be burdened with it” 
(P102). 
The second source of support identified were peer support networks. Local 
community groups were described as a positive source of peer support by several 
participants: “sometimes we just bounced off each other, you know, about things, which was 
quite good” (P103). The groups also appeared to provide a sense of meaning and purpose for 
some participants, providing opportunity to meet others with PD and to give something back 




Choosing to Engage in Support 
Informed Decision Making and Active Opt-In 
An issue that arose in many interviews related to providing patients with adequate 
appropriate information about the available services and allowing patients to make the 
decision on whether to attend: “I think if you tell people the right information they can make 
an informed choice. Just getting it right first time, getting it out there and then people can 
make up their own mind” (P102). Participants also noted the importance of not being put 
under pressure to attend: “I think it’s just you know making things a voluntary type of thing, 
you know people aren't being coerced into doing it” (P104) or to share unwillingly: “As long 
as you don’t push people to talk about things they don’t want to talk about” (P107). 
However, other participants advised that they would need to be “convinced” to try 
psychological support: “I guess somehow it would just be a case of trying to be… convinced 
that you can’t knock it ‘til you’ve tried it, you know?” (P111). This may also reflect the 
subtheme ‘Opinions of others’ whereby some would prefer for others to advise them that it 
would be helpful to try psychological support. Crucially, though, others can advise but the 
final decision must always be left to the patient themselves to actively opt-in or out. 
 
Perceived Effectiveness 
Some participants raised that their decision to engage in psychological support would 
be influenced by expectations of its effectiveness. When asked what would encourage them 
to participate in psychological support, one participant said: “Well improving my mind, my 
mood. If that… if you improve that” (P105). Considering this alongside the above subthemes 
regarding the opinions of others and informed decision making, it may be important to make 
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the potential benefits of psychological support apparent when it is offered: “If it's explained 
to the person properly that it's going to help them, what would they be feart of? Why would 
they no want to go through with it?” (P108). 
 
Meaningful Tailored Content 
Another factor that may impact on engagement is the content of what is being offered. 
When asked about preferences for the content of support, there was no unanimous preference 
across all participants. Some noted a desire for having a safe place to talk and be listened to, 
while others were looking for more practical coping strategies. One participant found CBT 
and Acceptance and Commitment Therapy (ACT) approaches helpful, while another was 
looking to discuss their worries, and another expressed a strong dislike for mindfulness, 
wellness and imagery approaches: “if I found out when I was due to go to a group thing that 
it was this wellness thing all the time, these fangled words don’t mean anything different. For 
me, it would still be a no” (P109). Similarly, participants had different aims for attending 
support, from reducing muscle tension and anxiety to improving mood, to gaining confidence 
in managing PD. Participants also had different preferences for the temporal focus of support. 
Some were looking for a here-and-now focus and were strongly against discussion of the 
possible progression of PD:  
I don’t want to know these things. I know about these things and I’ll face that when I 
come to it so I would hate for somebody to tell me what’s ahead. I know what’s 
ahead, I don’t need to be told and I'll deal with that when it comes. So that would be a 
definite no-no to me (P102).  
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Conversely, others expressed that they wanted to discuss the future and how life 
would be different with PD. 
This highlights the differences between individuals and the need for treatment content 
and aims to be individualised and meaningful to each person. Indeed, this was raised by 
several participants and it was noted that it would be helpful to advise people of treatment 
options:  
You could tell them what sort of things you can offer by the visit. Somebody who's 
further along would have different needs than somebody who's just been diagnosed. 
So maybe it would need to be suitable for the individual rather than just a group thing 
or just a set of questions or rules that you would have. You'd try and tailor it to the 
individual (P112). 
Similarly, participants advised that suggestions given in treatment would need to be 
manageable and realistic given the person’s age and the stage of PD:  
Some of the exercises they talk about like you know playing squash or racquet sports, 
well there’s no way on earth can I run around a squash court or a tennis court. I’m 
70 years of age with Parkinson's and all these other things wrong with me. So there’s 
no point in someone trying to encourage me to play tennis (P104).  
On a similar note, some participants mentioned helpful adaptations to therapy such as 
avoiding jargon, breaking down the conversation into manageable sections, and providing 
short handouts: “To break it down into fragments because... Well me, I tend not to- I take so 
much of the conversation and I don’t remember the rest. You know what I mean? It’s just 





The majority of participants indicated a preference for one-to-one psychological 
support over group support, with other participants being open to both formats. Several 
participants indicated they may be open to group psychological support following one-to-one 
appointments: “if I found out that it was a group thing I wouldn’t take part. Not immediately 
anyway” (P109) and “I think the one-to-one support was a good thing. If the sessions had 
continued maybe the next stage would have been meeting with other people” (P101). Most 
participants also expressed a preference for face-to-face appointments over video or phone 
call, but again some participants were open to all formats. 
Many participants indicated that shorter sessions would be better given the impact of 
PD on concentration: “I mean it’s about the concentration. And I know that’s something 
that’s altered for me, my spells of concentration have diminished a bit. So it would be... and I 
think thirty to forty-five minutes would be an ideal session” (P110). However, others had a 
preference for sessions of up to an hour. A suggestion from some participants was to offer 
30-minute sessions with the option of continuing for longer. This flexibility to the needs of 
each individual was again highlighted by participants as important for the format of support:  
I think it’s important for people to know that it would be tailored to their needs, you 
know it's not just one fits all.…People have to know that you know they’ll be treated 
as an individual and the service will be as much as possible focused around their 
needs i.e. times, dates, even if they need help with transport or… (P102).  
Participants also expressed different preferences for the frequency of psychological 
support, from weekly sessions to once every few months. Similarly, participants had different 
preferences for the overall duration of psychological support. The key here appears to be 
flexibility to individual preference and need:  
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It depends on the patient really wouldn’t it? I would imagine it might depend on how 
much the patient would need it. You know, so I think it would be good to let it roll 
until they say they don't want any more or they don’t need any more, or you think 
they’re maybe showing signs of improvement (P103).  
Several participants indicated that the time of day of sessions would also need to be 
flexible, taking into account their medication and symptoms: “I think Parkinson’s people 
tend to have a wee bit of bother getting going in the morning. So I’d say mid-morning” 
(P103) as well as their lifestyle and work: “Well it needs to be evenings because I work. I 
suppose lunch times also a good time for it” (P107). 
 
Barriers to Accessing Support 
Themes identified regarding barriers to accessing support are described below. 
Suggestions for strategies to overcome barriers derived from the barriers themselves and 











Suggestions for Overcoming Barriers to Accessing Psychological Support 
Suggestions for overcoming barriers 
Awareness 
• Increasing awareness and information about available support 
Resources and service access 
• Improving communication between professionals involved in the care of 
people with PD 
• Providing clarity on how to access psychological services 
• Offering referral for psychological support at diagnosis 
• Improving waiting times 
• Increasing availability of psychological support 
Attitudes of professionals 
• Building rapport 
• Respecting the patient and their decisions and preferences 
Location and setting 
• Local, easily accessible and non-stigmatised, neutral location e.g. GP surgery 
• Comfortable and non-clinical setting 
• Offering home visits 
Stigma 
• Increasing awareness and normalising psychological difficulties in PD 
Confidentiality 
• Providing clear information about confidentiality prior to accessing support 
and within both one-to-one and group support sessions 
Covid-19 
• Clinicians remaining accessible during lockdown periods 
• Psychological services continuing to accept referrals during lockdown periods 
• Respecting the preference of the patient for the format of support 
Group support concerns 
• Offering choice between one-to-one and group support 
• Selecting group participants at similar stages of PD with similar levels of 
mental health difficulties 
• Providing information about the characteristics of group members and what 








Participants spoke about the lack of awareness of psychological difficulties in PD: 
Depression is a big part of this disease. People think they’re going mad, they’re not 
really going mad. It is an apathy, depression and apathy. People who don’t- people 
seem to concentrate on the motor symptoms of the disease, not so much the 
psychological things (P107). 
As well as the lack of awareness of psychological services: “Well I actually haven't a 
clue about how... I don't know what functions you guys do or what's available or... how it 
would work or how it would happen. I'd need to be educated in that” (P112). The need to 
make this information more widely available was mentioned by several participants: “I would 
have to make an effort to try and do it so the more I know about it and how it works the more 
likely I am to actually access it” (P111). This links to the informed decision-making 
subtheme; awareness needs to be increased about available supports and what they involve to 
allow people to make an informed decision. 
Participants were asked about what would be helpful to include in an invitation letter 
for patients with PD about accessing psychological support. Participants’ suggestions have 
been collated and summarised in Box 2. Participants also suggested psychological services 
could be advertised through other healthcare professionals, leaflets, posters (e.g., in GP 
surgeries), newsletters, phone calls, email, social media, at PD clinics, and by giving 







Suggestions for Content of an Invitation Letter to Attend Psychological Support 
Suggestions for content of invitation letter 
• Who has been sent the letter and why 
• Normalising mental health difficulties in PD 
• Explaining what psychological support is and what is being offered, making it 
clear that the patient can opt-in and attendance is not compulsory 
• Aims of psychological support 
• Information about the effectiveness of psychological support (e.g. research 
evidence or anonymous testimonials) 
• What would be covered (e.g. content of sessions, type of approach), 
highlighting that this would be tailored to each individual’s needs and 
preferences 
• The format of support (e.g. one-to-one or group, face-to-face or video/phone 
call, time, day, session length, frequency, overall duration) and any flexibility 
within this to suit individual needs and preferences 
• If group support is being offered, providing information about the 
characteristics of the group (e.g. people recently diagnosed with PD) 
• Provision of any refreshments 
• Information about confidentiality  
• How to access the service (e.g. referral from GP or PD Nurse Specialist) 




Resources and Service Access 
An issue raised by some participants was difficulty accessing psychological services: 
“You’ve got to know where to go to get help. If you don’t know, that’s you, you’ve had it. I 
think- I don’t think that it’s openly available” (P106). A lack of resources was also 
highlighted by several participants: “I know at times there’s no availability for services 
because of the demand and finances so you’ve still got to be realistic” (P102). Slow access to 
adult mental health services was also reported: “People say there’s all this help available, but 
if you try to get the help you find that it’s not really available very quickly” (P104). This was 
76 
 
in contrast to another participant who found that specialist psychological support for PD was 
available quickly, which may reflect differences in waiting times between services and areas:  
Yes I was really surprised that I managed to... that I was seen so quickly. I can’t 
remember how quickly it was but I imagined there would be a very long waiting list, 
but I think I was seen within a month (P101).  
Suggestions to improve service access included offering psychological support at PD 
clinics and routinely offering psychological support following PD diagnosis. 
Many participants also raised a lack of coordination between services and the need to 
improve communication between different professionals involved in their care:  
It’s linkage between psychological services, my doctor and the Parkinson's 
specialists. ...I feel that my experience has been that it’s difficult for them all to work 
in coordination. I'm sure that psychological services send reports to my doctor and 
the Parkinson’s specialists but it’s sometimes difficult to get things done and to know 
who the right person is to approach (P101). 
 
Attitudes of Professionals 
Some participants described situations in which they were upset or annoyed by the 
manner or comments of healthcare professionals or group coordinators to the extent that they 
did not return to the service or group:  
I think it’s the people that take it. They either endear you to them or they don’t. I think 
that can be off-putting right away if you go in and you get this don’t care about you, 
don’t care what you attitude. That’s- that’s the way I felt. Never went back (P106).  
Others described more positive experiences: “[Name of clinician] was very... had a 
very good manner. I think she put me at my ease and I actually enjoyed the sessions” (P101). 
Important qualities participants identified in a clinician included: rapport, openness, good 
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listening skills, easy to talk with, empathy, having a nice and calming manner, smiling, and 
the ability to make the patient laugh and put them at ease. 
 
Location and Setting 
Locations that are far away or difficult to get to were reported by some participants as 
off-putting: “I suppose the only thing I could say that was unhelpful was I had to travel to get 
the support. …And I wasnae always up for driving that distance. So that’s the only difficulty 
though” (P110). Additionally, hospital locations were reported to cause anxiety and some 
locations were viewed as having negative connotations:  
It was quite intimidating going into that place the first time. …There’s a lot of drug 
users and things as well that go to that place as well. So I’m there thinking do folk 
think I’ve got a drug problem or a drink problem? (P107).  
The setting of the room in which psychological support takes place was also noted to 
be important: “Well it’s where you are. Where are you going to be doing the talking to this 
person? You need somewhere that you feel at ease. Sitting in an office like room with a desk 
between is not good” (P109).  
When planning the location, participants’ recommendations included: ensuring the 
location is accessible by public transport, car and taxi; considering patients’ mobility and the 
building accessibility (e.g. stairs, lifts); offering home visits; and conducting sessions in a 









Some participants felt that stigma could impact on willingness to access psychological 
support: “it’s the stigma of going to a Psychologist for a lot of people that puts them off” 
(P109). Others felt that stigma and acceptance of mental health issues is improving and more 
education about these issues is needed:  
I think we’re getting better at saying that mental health issues are just like- if 
somebody’s got a broken leg we sign the plaster or whatever you know. If somebody’s 
mind is broken we need to have that same acceptance. You know? It’s a break, it’s an 
illness. So we need to be educating folk that it’s the same kind of thing. It’s an illness, 
you know. So that I think- more education to acceptance. I think we’re on- we're 
getting on that right road. We’re certainly getting on that right road (P110). 
 
Confidentiality 
Several participants mentioned the importance of confidentiality: “I know it’s all 
confidential and if you want it to be confidential then it’s fine” (P107). Confidentiality within 
group settings was also raised as a concern by one participant: “with the confidentiality, you 
know that she had with us, you know, what happens in the group stays in the group. But then 
again you’re going right would you keep that?” (P103). Providing reassurance about 
confidentiality when offering psychological support was recognised as important: “Well I 
think everybody knows about confidentiality but it doesn’t harm to keep mentioning it 






The impact of the Covid-19 pandemic on the provision of healthcare services was 
brought up by many participants. Participants advised that their usual contact with healthcare 
professionals had decreased, local peer support groups had stopped meeting face-to-face and 
NHS group support had been paused since the beginning of the pandemic. 
As noted previously, most participants indicated a preference for face-to-face 
psychological support but many recognised this was not possible due to the pandemic. Some 
were willing to use video call as an alternative while others indicated this could be a barrier: 
“other than the business about face-to-face really would be the only thing that would kind of 
put me off a wee bit” (P111). Some felt the lack of face-to-face contact was impacting on 
their communication with healthcare professionals with potential knock-on impacts on their 
care:  
It’s difficult to at this particular time with the lockdown and that we’ve not had any 
specific person-to-person contact with the Parkinson’s specialist. The most I’ve had is 
a phone call. So that’s difficult to communicate what’s really going on in a short 
phone call (P101 member reflections).  
Given this, it is important that the impact of the pandemic on access to psychological 
services is minimised as much as possible. 
 
Group Support Concerns 
Several concerns about group support were voiced during the interviews. Worries 
about meeting new people and not feeling comfortable with others in a group were raised: 
“Well I get uptight meeting people so that would discourage me” (P105) and “I’d maybe feel 
a bit uncomfortable with people that I didn’t know. …Aye. It would maybe make me… I know 
it would make me anxious” (P112). 
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Concerns about the heterogeneity of group attendees were expressed by many 
participants. One aspect of this regarded differences in mental health needs: “I think it’s such 
a personal issue. And my mental health issues might be completely different from somebody 
else’s in a group” (P110) and worrying about others between sessions:  
But I feel like going to a mixed one, a mixed bag of people, it’s quite hard for you to 
understand and obviously you end up stressed going oh no, is he going to be ok? And 
you’re going to the next meeting going how are you? You know and you’re taking on 
somebody else’s problems (P103). 
Similarly, heterogeneity in the PD stage of attendees was a concern for many 
participants:  
Personally it's not for me because I just live a day at a time but I feel like if you go to 
these groups you might see people who are much more in advance and to me it’s a bit 
scary because you think am I going to end up like that? So yeah, personally that's why 
I don't go to these groups (P102).  
A potential solution to this barrier can be found by looking to a local peer support 
group which was set up for younger people at similar stages of PD. It would also be 
important for group members to have similar mental health needs, and choice offered 






The interview data gave rise to a breadth of information not anticipated at the 
beginning of the project, and the final themes reflect a number of factors influencing people 
with PD when considering accessing psychological support. This was distilled down to three 
main themes: perceived need for support, choosing to engage in support, and the barriers to 
accessing support. 
The perceived need for support appears to be driven by three subthemes. Participants 
indicated that symptoms would need to reach a certain level of severity before psychological 
support was accessed. The concept of resilience and reluctance to acknowledge the need for 
support were also discussed. The characteristic of “strength” has historically been regarded as 
an admirable quality in the geographical area in which the study was conducted. This may be 
underlying some participants’ reluctance to seek help. It may be that the concepts of “needing 
support” and “resilience” act in opposition with one another, whereby it is felt that the 
characteristic of “strength” needs to be put aside or reduced in order for one to be able to seek 
support, leading to reluctance to seek support until eventually feeling that problems are 
“severe enough” that professional help is required. 
Others’ opinions were also found to be important in identifying the need for help, and 
at times others identified this need prior to the participant themselves. This idea was reflected 
in recruitment for the current study. Participants who were invited to take part were identified 
by a PD CNS as having had difficulties with mental health, while participants themselves did 
not all self-identify as having had mental health difficulties. Linking to the previous 
subtheme, it may be that participants did not feel their difficulties were “severe enough” to 
warrant a label of mental health difficulties, or these participants may be reluctant to apply 
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the label of “mental health difficulties” to themselves for the reasons discussed above, which 
may account for this difference.  
The quality and utilisation of participants’ support networks was also found to impact 
on the perceived need for support. Family, friends and local peer support groups were all 
identified as important sources of social support. However it was recognised that social 
support does not offset the need for psychological support when symptoms are more severe. 
The second theme ‘Choosing to engage in support’ explored the factors influencing 
the choice to engage in support, given a need for support has been identified. In other words, 
what makes people want to engage in support? The subthemes ‘Meaningful tailored content’ 
and ‘Flexible format’ correspond to the first research question: ‘What are the preferences of 
patients with PD for the content and format of support for psychological wellbeing?’ The key 
messages of these subthemes were the differences between individuals and the need to tailor 
the content and format of psychological support to individual preference and need. 
The third theme corresponds to the second research question: ‘What views and 
experiences do patients have on the barriers to participation in psychological support and how 
these can be overcome?’ Within the ‘Awareness’ subtheme, participants’ suggestions for the 
content of an invitation letter to attend psychological support were collated, corresponding to 
the third research question: ‘What are the opinions of patients on what would be helpful to 
include in an initial invitation letter to be sent to patients to provide more information about 
the services offered?’ It is important to note that suggestions made regarding strategies to 
overcome barriers and content of an invitation letter need to be considered in the context of 
the current study, and readers must consider if these recommendations are appropriate for 
other settings and contexts.  
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Several of the subthemes identified in the current study correspond to barriers and 
issues identified in previous research. For example, the subtheme in the current study of 
‘Location and setting’ corresponds to location and transport issues identified in previous 
research (Dobkin et al., 2013; Oehlberg et al., 2008; Sajatovic et al., 2017). In common with 
two previous studies, stigma was also identified as a barrier (Oehlberg et al., 2008; Troeung 
et al., 2015). Troeung et al. (2015) identified that younger age and expectations of the 
effectiveness of interventions predicted uptake of services. The current study also identified 
perceived effectiveness as a key consideration when choosing whether to access 
psychological services. Younger age was not identified as a factor in the current study 
however the age range of the sample was relatively young, and so the views of older patients 
with PD may have differed. Sajatovic et al. (2017) found that running sessions at fixed times 
made group participation more difficult, and the time of sessions was also identified in the 
current study within the subtheme ‘Flexible format’ as a consideration when deciding 
whether to access support. Other barriers identified by Dobkin et al. (2013) included the 
availability of services in the local community and lack of quality treatment options, which 
correspond with subthemes in the current study regarding location and setting, resources and 
service access, and meaningful tailored content. Dobkin et al. (2013) also report barriers such 
as “Anyone in my situation would be struggling” and “Doctors are not sensitive enough to 
PD related issues” which are reflected in the current study in discussions around perceived 
need for support, lack of awareness and issues regarding service access. Interestingly, another 
barrier identified by these authors was physical impairments, which was not found to be a 
barrier in the current study. This may be due to overlap with other subthemes such as 
‘Location and setting’ which covered concerns about mobility and physical access. Another 
potential reason for this discrepancy may be differences in the severity of PD between 
participants in the two studies. In the current study only two participants identified the impact 
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of their PD as severe, with most reporting a moderate impact. The Dobkin et al. (2013) 
questionnaire study had a very large sample which may have included more individuals at 
advanced stages of PD. Finally, Oehlberg et al. (2008) found that some patients reported 
concerns around talking about personal problems to people they did not know. Similar topics 
arose in the current study within subthemes of ‘Confidentiality’ and ‘Attitudes of 
professionals’ in discussions around the importance of building rapport. 
The current study mirrors previous findings and delineates the different factors 
associated with the perceived need for support, the choice to engage in psychological support, 
and barriers to accessing support. This study also expands on previous findings through the 
identification of barriers regarding group psychological support and the impact of the Covid-
19 pandemic, as well as investigating preferences for the content and format of support, and 
exploring strategies to overcome barriers. 
One potential limitation of the study pertains to the recruitment process and resulting 
sample. As noted previously, forty patients were sent invitation letters to participate and 
fourteen responses were received. Thus, it may be that the final sample were particularly 
proactive and had considerably positive or strong opinions regarding psychological support. 
Another potential limitation is that participants may have been reluctant to share 
negative opinions of psychological services given the researcher’s role within these services. 
However, participants were made aware at the stage of consent that their participation would 
not impact on their care and many participants offered constructive feedback during 
interviews. On a similar note, the lead researcher’s role in these services may have influenced 
the co-constructed meanings produced from the interviews themselves as well as analysis and 
interpretation. Given the researcher’s epistemological stance, this is not considered a 
limitation in itself but reinforces the contextual nature of the results. 
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Another limitation is that data on ethnicity and sexuality were not gathered during the 
project due to concerns regarding identification of individuals in a small sample. However, 
given the possibility for these factors to give rise to differences in meaning in qualitative 
research (Tracy, 2010), it would have been advantageous to gather this information. 
Strengths of the study include its methodological rigour and use of reflective 
practices. The reflective log kept by the lead researcher throughout the project was used to 
document reflections and reflexivity, including the researcher’s potential contextual 
influences on data collection, analysis and interpretation. A second researcher reviewed one 
full indexed interview transcript to enrich the analysis process and incorporate an additional 
perspective. Member reflections were also invited from two participants, and their 
clarifications and reflections were incorporated into the final results. The sample included 
participants who had previously sought psychological support and those who had not, which 
provided a more diverse perspective on the process of accessing services and potential 
barriers. Additionally, SIMD data suggested that the sample represented individuals from a 
range of socio-economic backgrounds. 
The findings of the current study have clinical implications for promoting access to 
psychological services for individuals with PD and several suggestions are made throughout 
the paper regarding this. However, it must be noted that this was a qualitative study 
conducted with a small sample of individuals with PD in a specific geographical area within 
the UK NHS. Consequently, care must be taken when considering generalising findings to 
other contexts and populations. Nonetheless, this study provides a valuable insight into the 
preferences, opinions and experiences of individuals with PD regarding psychological 
support for wellbeing. Future research in this area could explore the opinions of older patients 
at later stages of PD regarding psychological support, as well as the opinions of carers and 
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family members. It would be interesting to note if the preferences and opinions of these 
groups differed and if so, how could psychological services be improved for these groups. 
 
Conclusion 
This study explored the preferences, opinions and experiences of patients with PD 
regarding psychological support for wellbeing. Three interlinked factors were identified 
which influence people with PD when accessing psychological support: perceived need for 
support, choosing to engage in support, and the barriers to accessing support. Participants 
expressed the importance of tailoring the content and format of support to individual need 
and preference. Other factors impacting access to psychological services were explored, with 
several barriers to accessing services identified and suggestions given on strategies to 
overcome these barriers. The findings demonstrate the importance of increasing awareness of 
psychological services, improving service accessibility, and identifying the individual needs 
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1. What do we publish? 
1.1 Aims & Scope 
Before submitting your manuscript to Journal of Geriatric Psychiatry and Neurology, 
please ensure you have read the Aims & Scope. 
1.2 General Instructions 
Manuscripts should be submitted electronically 
to https://mc.manuscriptcentral.com/jgpn.  
All material (abstracts, keywords, text, tables, and figure captions) should be typed 
double-spaced. Computer preparation is mandatory. Subheading should be used to 
designate the different sections of the text. References should be numbered 
consecutively throughout the text. Provide a list of three to six keywords to assist 
indexing of the article. 
Articles of any length are considered. 
Title page: The title should be brief and meaningful. The authors’ first and last 
names, academic or medical degrees, and affiliations should follow the title. 
Authorship should be limited to direct participants, although technical assistance can 
be acknowledged as a footnote. A separate paragraph should identify where the 
work was done, if supported by a grant or otherwise, and the meeting, if any, at 
which the paper was presented. 
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Abstract: An abstract of approximately 150 words should be provided on. This 
abstract should be factual and should present the reason for the study, the main 
findings, and the principal conclusions. 
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• The title “References” is centered at the top of a separate page at the end of the 
document. 
• Entries are preceded by their number and are given in numerical order. 
• The reference list should be single-spaced. Single-space between entries. 
• The second line and all subsequent lines of each item in the reference list should be 
indented (hanging indent). 
• Do not use “et al.” in the Reference list at the end; names of all authors of a 




Appendix 1.2 Search strategy for each database 
 
Ovid Medline: 
 1 Randomized controlled trials as Topic/ 
  2 Randomized controlled trial/ 
  3 Random allocation/ 
  4 Double blind method/ 
  5 Single blind method/ 
  6 Clinical trial/ 
  7 exp Clinical Trials as Topic/ 
  8 or/1-7 
  9 (clinic$ adj trial$1).tw. 
  10 ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw. 
  11 Placebos/ 
  12 Placebo$.tw. 
  13 Randomly allocated.tw. 
  14 (allocated adj2 random).tw. 
  15 or/9-14 
  16 8 or 15 
  17 Case report.tw. 
  18 Letter/ 
  19 Historical article/ 
  20 Review of reported cases.pt. 
  21 Review, multicase.pt. 
  22 or/17-21 
  23 16 not 22 
  24 exp Parkinsonian Disorders/ 
  25 parkinson*.tw. 
  26 24 or 25 
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  27 exp Psychotherapy/ 
  28 exp social support/ 
  29 exp Self-Help Groups/ 
  30 exp Adaptation, Psychological/ 
  31 psychosocial intervention*.tw. 
  32 social support.tw. 
  33 social network*.tw. 
  34 support system*.tw. 
  35 self-help group*.tw. 
  36 support group*.tw. 
  37 educational therapy.tw. 
  38 psychotherapy.tw. 
  39 behavio* therapy.tw. 
  40 family therapy.tw. 
  41 group therapy.tw. 
  42 group intervention*.tw. 
  43 cogniti* therapy.tw. 
  44 psychological adjustment*.tw. 
  45 psychological adaptation.tw. 
  46 adaptive behavio*.tw. 
  47 coping behavio*.tw. 
  48 coping intervention*.tw. 
  49 coping strateg*.tw. 
  50 coping skill*.tw. 
  51 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 
or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 






1 Clinical trial/ 
2 Randomized controlled trial/ 
3 Randomization/ 
4 Single blind procedure/ 
5 Double blind procedure/ 
6 Crossover procedure/ 
7 Placebo/ 
8 Randomi?ed controlled trial$.tw. 
9 Rct.tw. 
10 Random allocation.tw. 
11 Randomly allocated.tw. 
12 Allocated randomly.tw. 
13 (allocated adj2 random).tw. 
14 Single blind$.tw. 
15 Double blind$.tw. 
16 ((treble or triple) adj blind$).tw. 
17 Placebo$.tw. 
18 Prospective study/ 
19 or/1-18 
20 Case study/ 
21 Case report.tw. 
22 Abstract report/ or letter/ 
23 or/20-22 
24 19 not 23 
25 exp Parkinsonian Disorders/ 
26 parkinson*.tw. 
27 25 or 26 
28 exp Psychotherapy/ 
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29 exp social support/ 
30 exp Self-Help Groups/ 
31 exp Adaptation, Psychological/ 
32 psychosocial intervention*.tw. 
33 social support.tw. 
34 social network*.tw. 
35 support system*.tw. 
36 self-help group*.tw. 
37 support group*.tw. 
38 educational therapy.tw. 
39 psychotherapy.tw. 
40 behavio* therapy.tw. 
41 family therapy.tw. 
42 group therapy.tw. 
43 group intervention*.tw. 
44 cogniti* therapy.tw. 
45 psychological adjustment*.tw. 
46 psychological adaptation.tw. 
47 adaptive behavio*.tw. 
48 coping behavio*.tw. 
49 coping intervention*.tw. 
50 coping strateg*.tw. 
51 coping skill*.tw. 
52 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 
or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 







S22 S3 AND S21  
S21 S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 
OR S15 OR S16 OR S17 OR S18 OR S19 OR S20  
S20 TI ( "psychosocial intervention*" or "social support" or (social n1 network*) or 
(support n1 system*) or (self-help n1 group*) or (support n1 group*) or “educational 
therapy*” or psychotherapy or "behavio* therapy" or "family therapy" or "group therapy" or 
"group intervention*" or "cognitive therapy" or "cognition therapy" or (psychological n1 
adjustment) or "psychological adaptation" or "adaptive behavio*" or "coping behavio*" or 
"coping intervention" or "coping strateg*" or "coping skill*" ) OR AB ( "psychosocial 
intervention*" or "social support" or (social n1 network*) or (support n1 system*) or (self-
help n1 group*) or (support n1 group*) or “educational therapy*” or psychotherapy or 
"behavio* therapy" or "family therapy" or "group therapy" or "group intervention*" or 
"cognitive therapy" or "cognition therapy" or (psychological n1 adjustment) or 
"psychological adaptation" or "adaptive behavio*" or "coping behavio*" or "coping 
intervention" or "coping strateg*" or "coping skill*" ) 
S19 DE "Psychoeducation"  
S18 DE "Coping Behavior" OR DE "Coping Style"  
S17 DE "Adaptive Behavior"  
S16 DE "Group Intervention"  
S15 DE "Family Therapy" OR DE "Conjoint Therapy" OR DE "Strategic Family 
Therapy" OR DE "Structural Family Therapy"  
S14 DE "Educational Therapy"  
S13 DE "Mindfulness-Based Interventions"  
S12 DE "Behavior Therapy"  
S11 DE "Anxiety Management"  
S10 DE "Cognitive Therapy"  
S9 DE "Cognitive Behavior Therapy" OR DE "Acceptance and Commitment Therapy" 
OR DE "Cognitive Processing Therapy" OR DE "Prolonged Exposure Therapy"  
S8 DE "Emotional Adjustment"  
S7 DE "Self-Help Techniques" OR DE "Self-Management"  
S6 DE "Support Groups" 
S5 DE "Social Support"  
S4 DE "Psychotherapy" OR DE "Adlerian Psychotherapy" OR DE "Adolescent 
Psychotherapy" OR DE "Affirmative Therapy" OR DE "Analytical Psychotherapy" OR DE 
"Autogenic Training" OR DE "Brief Psychotherapy" OR DE "Brief Relational Therapy" OR 
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DE "Child Psychotherapy" OR DE "Client Centered Therapy" OR DE "Conversion Therapy" 
OR DE "Couples Therapy" OR DE "Eclectic Psychotherapy" OR DE "Emotion Focused 
Therapy" OR DE "Existential Therapy" OR DE "Experiential Psychotherapy" OR DE 
"Expressive Psychotherapy" OR DE "Eye Movement Desensitization Therapy" OR DE 
"Feminist Therapy" OR DE "Geriatric Psychotherapy" OR DE "Gestalt Therapy" OR DE 
"Group Psychotherapy" OR DE "Guided Imagery" OR DE "Humanistic Psychotherapy" OR 
DE "Hypnotherapy" OR DE "Individual Psychotherapy" OR DE "Insight Therapy" OR DE 
"Integrative Psychotherapy" OR DE "Interpersonal Psychotherapy" OR DE "Logotherapy" 
OR DE "Narrative Therapy" OR DE "Network Therapy" OR DE "Persuasion Therapy" OR 
DE "Primal Therapy" OR DE "Psychoanalysis" OR DE "Psychodrama" OR DE 
"Psychodynamic Psychotherapy" OR DE "Psychotherapeutic Counseling" OR DE 
"Psychotherapeutic Techniques" OR DE "Rational Emotive Behavior Therapy" OR DE 
"Reality Therapy" OR DE "Relationship Therapy" OR DE "Solution Focused Therapy" OR 
DE "Strategic Therapy" OR DE "Supportive Psychotherapy" OR DE "Transactional 
Analysis" 
S3 S1 OR S2  
S2 TI parkinson* OR AB parkinson*  
S1 DE "Parkinson's Disease" OR DE "Parkinsonism" 
 
CENTRAL database: 
#1 MeSH descriptor: [Parkinson Disease] explode all trees 
#2 parkinson*:ti,ab 
#3 #1 or #2 
#4 MeSH descriptor: [Social Support] explode all trees 
#5 MeSH descriptor: [Self-Help Groups] explode all trees 
#6 MeSH descriptor: [Psychotherapy] explode all trees 
#7 MeSH descriptor: [Adaptation, Psychological] explode all trees 
#8 "psychosocial intervention*":ti,ab or "social support":ti,ab or (social next 
network):ti,ab or (support next system*):ti,ab or (self-help next group*):ti,ab or (support next 
group*):ti,ab or "educational therapy*":ti,ab or psychotherapy:ti,ab or "behavio* 
therapy":ti,ab or "family therapy":ti,ab or "group therapy":ti,ab or "group intervention*":ti,ab 
or "cognitive therapy":ti,ab or "cognition therapy":ti,ab or (psychological next 
adjustment):ti,ab or "psychological adaptation":ti,ab or "adaptive behavio*":ti,ab or "coping 
behavio*":ti,ab or "coping intervention":ti,ab or "coping strateg*":ti,ab or "coping 
skill*":ti,ab 
#9 #4 or #5 or #6 or #7 or #8 




Appendix 2.1 Major research project revised proposal 
 
Abstract 
Background: Parkinson's disease is associated with high rates of depression and 
anxiety, for which group Cognitive Behavioural Therapy (CBT) may be an effective 
treatment. However, previous studies suggest that uptake of group CBT in this 
population is limited, and this was also the experience of the Neuropsychology and 
Older Adult services in NHS Ayrshire & Arran when these services offered a group 
CBT intervention to patients with Parkinson's disease. 
Aims: The aim of this project is to gain a better understanding of the preferences of 
service users with Parkinson's disease for psychological support, and how barriers to 
participation can be overcome. 
Methods: One-to-one semi-structured interviews will be conducted with 10-12 
service users aged 18 or over with Parkinson's disease in the NHS Ayrshire & Arran 
health board, with questions covering topics such as content and format of 
psychological support, and barriers to participation. Framework analysis will be 
conducted on the resulting data to identify themes that emerge from the interviews, 
and member checks will be carried out to increase credibility of the results. 
Applications: Results from the interviews will be used to develop recommendations 
for providing psychological support for people with Parkinson's disease, and will be 






Parkinson's disease is a neurodegenerative disorder characterised by both motor 
symptoms, such as a resting tremor and rigidity, and non-motor symptoms, such as 
cognitive and olfactory problems (Prediger et al., 2012). Parkinson's disease is also 
associated with high rates of depression and anxiety, with studies estimating the 
prevalence of depression at around 31% (Slaughter et al., 2001), and the prevalence 
of anxiety also at 31% (Broen et al., 2016). There are limited available treatments for 
mood disorders in Parkinson's disease (Chen & Marsh, 2014). However, there is 
some evidence to suggest that a Cognitive Behavioural Therapy (CBT) approach 
may be effective in reducing depression and anxiety symptoms in individuals with 
Parkinson's disease (Bomasang-Layno et al., 2015; Egan, Laidlaw & Starkstein, 
2015). 
A small number of studies have also investigated the efficacy of group interventions 
for mood, anxiety and wellbeing in Parkinson's disease. Group interventions may be 
more cost effective than one-to-one therapy (Brown, 2011; McDermut, Miller & 
Brown, 2001), and the group format may provide other benefits to participants 
(Whitfield, 2010), including a feeling of social cohesion that has been reported in 
some group interventions for Parkinson's disease (Fitzpatrick, Simpson & Smith, 
2009; Pohl et al., 2020). 
One study into group interventions from Hadinia et al. (2017) compared group CBT 
to a health enhancement programme for patients with Parkinson's disease, and 
found CBT to be more effective in reducing stress and improving quality of life. In 
another group intervention study, Troeung, Egan and Gasson (2014) found that 
group CBT reduced levels of depression and anxiety in comparison to a waitlist 
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control, and these effects were maintained at a 6-month follow-up. Similar results 
have also been reported in two small uncontrolled studies into group CBT for 
depression and anxiety in Parkinson's disease (Berardelli et al., 2015; Feeney, Egan 
& Gasson, 2005). 
However, in two of these group intervention studies there was a notable dropout of 
participants from expression of interest in the study to participation. Hadinia et al. 
(2017) report recruiting 41 patients, 11 of whom dropped out. Reasons for drop out 
included: participants choosing not to continue, or missing two or more sessions, and 
health related problems. In addition, Troeung, Egan and Gasson (2014) noted 
dropout of individuals from expression of interest in the study to participation. They 
report that 45 people indicated their interest in taking part, 16 of whom later opted 
out after they were given more information about the study. Six participants indicated 
this was due to various practical reasons, while the remaining ten did not give a 
reason.  
This experience of substantial drop-out rates has also been mirrored in a 
Psychological service setting. In NHS Scotland's Ayrshire & Arran health board, the 
Neuropsychology and Older Adult services developed a psychological wellbeing 
group for people with Parkinson's disease based on CBT approaches. The services 
gave a presentation to referring clinicians regarding the use of a "distress 
thermometer" tool to identify potential emotional problems, and some information 
about the group itself, so they would have a clear understanding of the group's 
purpose and content in order to inform patients. However, when the service offered 
the group intervention to patients with Parkinson's disease, patients either did not opt 
in, or agreed to be referred to the group but then opted out when they received a 
letter with more information, and so the group was not run. The service has identified 
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that the content or format of the intervention offered may not have been in line with 
the needs and wants of service users with Parkinson's disease for psychological 
support. Additionally some practical components of the group, such as time of day, 
may have created barriers for some service users accessing the group intervention. 
The idea that practical issues may have been a barrier to participation is supported 
by findings from a study from Sajatovic et al. (2017) into group exercise interventions 
for people with Parkinson's disease. In this study participants reported that they 
enjoyed the social aspects of groups but found it difficult to attend group sessions at 
fixed times, and problems with transportation and getting to the locations for the 
groups made participation more difficult. Similarly, Dobkin et al. (2013) surveyed 
individuals with Parkinson's disease and found that issues with transport, availability 
of services and physical impairments were perceived as barriers to using mental 
health services. 
Another survey study from Troeung et al. (2015) found that younger age and a belief 
that mental health interventions will be effective were significant predictors of uptake 
of mental health care, while stigma was reported as a concern for a small proportion 
of people with Parkinson's disease. A qualitative study from Oehlberg et al. (2008) 
also found that some participants with Parkinson's disease had concerns about 
engaging in psychotherapy due to stigma, as well as discomfort in talking about 
personal problems to people they did not know, and issues with transportation. 
 
If stigma is a concern for some patients then a group format may help to overcome 
this barrier. It has been suggested that group CBT may help to decrease stigma due 
to the normalisation inherent in participating in a group with others experiencing 
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similar problems (Whitfield, 2010). However, the lack of engagement in the group 
intervention offered by NHS Ayrshire & Arran described above indicates that there 
may be other barriers preventing service users from engaging with this intervention. 
As negative expectations about group therapy may reduce its effectiveness and 
increase drop-out rates (Westra, Dozois, & Boardman, 2002), it is important to 
establish service users' initial engagement in support offered by Psychology services 
prior to commencement. Thus, a better understanding of service user preferences 
for psychological support, and the barriers to engaging in this support, is required. 
The previous research described above has mainly been quantitative, with a lack of 
scope for further exploration of participant views. Additionally, the one qualitative 
study from Oehlberg et al. (2008) touched on barriers to engaging in psychotherapy 
but did not explore service users' treatment preferences for psychological 
interventions.  
Consequently, this study will aim to form a better understanding of the preferences of 
service users with Parkinson's disease for psychological support, and how barriers to 
participation can be overcome. The results will be used to guide recommendations 
for services for psychological support offered to patients with Parkinson's disease. 
This will inform the support offered by services in NHS Ayrshire & Arran, and can be 
utilised in other Neuropsychology and Older Adult services further afield. By 
developing psychological support for patients with Parkinson's disease driven by the 
preferences and experience of patients themselves, it is hoped that service user 






Aims and Hypotheses 
Aims 
The aim of this project is to gain a better understanding of the preferences of service 
users with Parkinson's disease for psychological support, and how barriers to 
accessing this form of support can be overcome. This information will be used to 
inform recommendations for the adaptation of psychological support offered to 
patients with Parkinson's disease. 
Research questions 
1. What are the preferences of service users with Parkinson's disease for the content 
and format of support for psychological wellbeing? 
2. What views and experiences do service users have on the barriers to participation 
in psychological support and how these can be overcome? 
3. What are the opinions of service users on what would be helpful to include in an 
initial invitation letter to be sent to patients in NHS Ayrshire & Arran to provide more 
information about the services offered. 
 
Plan of Investigation 
Participants 
Participants will be ten to twelve adults with a diagnosis of Parkinson's disease living 
within the NHS Ayrshire & Arran health board. 
Inclusion and Exclusion Criteria 
107 
 
Inclusion criteria: Participants must have a clinical diagnosis of idiopathic Parkinson's 
disease, have experienced problems with their mental health, be aged 18 or over, be 
fluent in English, have the capacity to provide informed consent to take part in the 
interview, be able to contribute independently to the interview, and be able to take 
part in the interview either over the phone or using video conferencing software. 
Exclusion criteria: Service users with a diagnosis of dementia will not be invited to 
participate in the interviews, as the needs of these service users may differ.  
Recruitment Procedures 
Participants will be recruited through NHS Ayrshire & Arran services, from the North, 
East and South Ayrshire Health and Social Care Partnerships. Parkinson's disease 
clinical nurse specialists working in the service have agreed to assist in recruitment. 
Parkinson's disease nurses will review their caseload and purposively select patients 
who would be suitable to participate in the interviews, based on the above inclusion 
and exclusion criteria. Participants selected will represent a mix of patients who were 
previously offered the group intervention described in the introduction and/or one-to-
one support, and patients who have not previously received psychological support. 
After suitable patients have been identified, they will be sent an invitation letter by 
Parkinson's disease nurses, which will include an information sheet and pre-
addressed and pre-paid reply slip. Patients will be asked to indicate on the reply slip 
whether or not they would like to participate in the interviews, and if they consent to 
be contacted by the researcher. If patients do not respond to the letter within two 
weeks, Parkinson's disease nurses may telephone call as a reminder to return the 
reply slip. Patients who express interest over the phone will be asked to confirm if 
they consent to being contacted by the researcher. Patients who indicate an interest 
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in participating will then be contacted by the researcher to provide the opportunity for 
patients to ask questions about the study, and to arrange a time for the interview if 
they would like to take part. 
Measures 
The interview schedule will be developed based on the research questions and 
previous literature. After the schedule has been drafted, local clinicians and 
members of the charity Parkinson's Disease UK will be asked to review the 
questions and provide feedback. This feedback will then be used to redraft the 
questions as necessary to create the final interview schedule. 
The schedule will cover topics such as: content of psychological support, format and 
practicalities of the sessions, what participants would hope to gain from 
psychological support, barriers to participation and how these could be addressed 
(Krueger et al., 2013; Letourneau et al., 2012; Todd, Jones & Lobban, 2013). 
Participants will also be asked for their opinions on what would be helpful to include 
in an initial invitation letter sent to patients in NHS Ayrshire & Arran to provide more 
information about the psychological services offered.  
Design 
This study will employ a qualitative interview design.  
Research Procedures 
Parkinson's disease nurses will be asked to gather basic data from medical records 
on participant age, gender, and number of years since a diagnosis of Parkinson's 
disease was received. Participants will then be asked further demographic self-report 
questions, some of which are adapted from Dobkin et al. (2013), such as: marital 
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status; occupation or previous occupation; the type of accommodation the person is 
currently living in (e.g. rented, owned, supported accommodation); the extent to 
which PD symptoms affect the patient's ability to participate in activities of daily living 
(mildly, moderately, extremely); the number of other medical conditions the person is 
currently diagnosed with; if the patient has ever had any concerns about their mood 
or wellbeing, or felt they needed help managing their mood or wellbeing; and their 
postcode in order to calculate the SIMD (Scottish Index of Multiple Deprivation). 
During the interviews, participants will be asked questions from the interview 
schedule, plus any clarifying questions as needed. Participants will also be asked if 
they would be willing to participate in member checks (discussed in more detail 
below), and if they consent to being re-contacted for this purpose at a later date. 
Interviews will be recorded using audio recording software. The researcher will take 
notes during the data collection and analysis phases, to provide a reminder of issues 
not captured in the transcripts (such as contextual information) and to support the 
researcher's reflexivity. Following the interviews, participants will be debriefed and 
sent an information sheet detailing what to do if they are feeling distressed as a 
result of the interview. If a participant has given consent to be re-contacted, then 
they may be contacted by phone or email following the interview and subsequent 
analysis for member checking. This will involve the researcher providing the 
participant with a summary of the main themes, conclusions and interpretations of 
the data (Embi et al., 2004). Participants will be asked to check the accuracy of 






Audio recordings from the interviews will first be transcribed by the researcher. 
NVivo software may be used to help organise the data. Framework analysis (Ritchie 
& Spencer, 2002) will then be conducted on the transcripts to identify key themes in 
the data. Framework analysis is type of thematic analysis that is a grounded and 
systematic approach to synthesising and interpreting qualitative data (Ritchie & 
Spencer, 2002). It was chosen as the analysis method for the current study as it is a 
thematic approach in which themes can be identified both from the data itself and 
from the original research questions (Rabiee, 2004), and it is regularly used for 
analysing data from semi-structured interviews (Gale et al., 2013). The researcher's 
theoretical stance is one of contextual constructionism. This epistemology posits that 
the analysis process and subsequent findings are subjective and dependent on the 
context of the participants and researcher, although still grounded in participant 
accounts. The goal of analysis is therefore to develop a richer understanding rather 
than to discover objective 'truths' (Madill, Jordan & Shirley, 2000). 
Data will be organised and interpreted using the five-step approach proposed by 
Richie and Spencer (2002). The first stage will involve the researcher familiarising 
themselves with the data by listening to and reading interview transcripts, and noting 
any emerging themes. A combined inductive and deductive approach will then be 
taken to construct a thematic framework. This will be done by identifying themes 
driven by the interview schedule itself, issues expressed by participants, and 
concepts that emerge from patterns or repetitions in discussions with participants. 
The third stage will involve the researcher indexing the individual interview 
transcripts according to the framework, and the fourth will involve rearranging 
summarised versions of the data in a chart according to theme rather than individual. 
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The final stage will involve the researcher analytically studying the charted data to 
discover patterns and explanations, and using these findings to inform 
recommendations for improving psychological support for patients with Parkinson's 
disease. Coding will be carried out by the researcher, and two separate portions of 
the transcripts will also be coded by the Academic and Field Supervisors to provide 
additional perspectives and enrich the analysis. Member checks will also be carried 
out in order to increase the credibility of the findings and methodological rigour of the 
study. Any clarifications or corrections participants identify through member checking 
will be addressed and incorporated into the analysis. 
Justification of sample size 
The sample sizes detailed in previous qualitative interview studies utilizing the 
framework approach have varied substantially, from samples of 6 participants 
(Hackett & Strickland, 2018) through to samples as large as 77 participants 
(Parkinson et al., 2016). However, there often does not appear to be any clear 
theoretical justification for the choice of sample size, and this is a problem that has 
been reported in the wider field of qualitative health research (Vasileiou et al., 2018). 
The concept of theoretical saturation is used by some papers to justify sample size, 
and saturation has been reported by some researchers early in the process of 
thematic analysis of individual interviews. For example, Guest et al. (2006) reported 
that broad themes became apparent after analysis of just 6 interviews, and Hennink 
et al. (2017) reported discovering 84% of codes by the 6th interview they carried out. 
Given the possibility that saturation may require more interviews than in the above 
studies, and so that a representation of different participants can be included, this 
study will aim to recruit 10 participants. This number is also pragmatic for a doctorate 
project and should be achievable given the population the study will be recruiting 
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from. However, if data saturation has not been reached following the initial 10 
interviews, the sample size may be increased to 12 participants. If saturation is 
reached prior to 10 interviews, all 10 interviews will still be carried out in order to 
determine if any new themes arise from the additional interviews.  
Settings and Equipment 
Interviews will be conducted either by telephone or using secure video conferencing 
software, such as Microsoft Teams. Audio recording software, such as the recording 
function in Microsoft Teams, will be used to record interviews. Interviews will then be 
transcribed, either using the transcript function in Microsoft Teams, or by a member 
of the research team. If needed, a laptop will be used to transcribe the audio 
recordings, and a transcription pedal will be used if available and required. 
 
Health and Safety Issues 
Researcher Safety Issues 
Interviews will be conducted remotely, either by telephone or video conferencing 
software, so the researcher will not have any direct contact with patients. 
Participant Safety Issues 
Interviews will be conducted remotely so that participants will not need to have any 
direct contact with researchers. The researcher will check the local policy that is 
followed when service users become distressed during remote clinical contact, and 
what is done if a call with a service user is cut off while they are distressed. This 
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policy will then be followed in the event that any participant does become distressed 
and the call is cut off.  
 
Ethical Issues 
Approval will be sought from NHS R&D and NHS Ethics. Data will be stored and 
processed in line with GDPR guidelines. Notes from interviews and any written forms 
completed by participants will be stored in a locked cabinet at an NHS and/or 
University of Glasgow site. Personal data gathered during the study will be stored in 
a password protected file on a secure NHS and/or University of Glasgow drive. 
Audio recordings of interviews will also be uploaded to an NHS and/or University of 
Glasgow computer and saved on a secure NHS and/or University of Glasgow drive. 
Other ethical considerations such as confidentiality and informed consent will be 
considered and addressed in ethics applications. Participants will also be asked to 
consent in writing to participation in the interviews and to the interviews being 
recorded, transcribed, and selected quotations being used in published and 
disseminated reports. Participants will also be asked whether they consent to being 
contacted following the interview for member checking purposes, and it will be 
advised that this an optional addition to the main interview. It is not anticipated that 
the interview questions should cause distress, however if any participant should 
become distressed during the interviews then the researcher will follow relevant local 






Costs to be covered will include: audio recording software to record interviews (if 
needed); stationery for taking notes during interviews; stationery for invitation letters, 
information sheets, consent forms, envelopes; postage.  
Some previous research studies have reported difficulties with recruitment of service 
users with Parkinson's disease, and as such this population can be difficult to reach. 
Consequently, and if feasible, participants will be offered a £5 supermarket voucher 
as a thank you for their time. This may increase rates of participation and may help 
to ensure that participation in the interviews is not influenced by economic factors, 





Draft proposal 09/12/2019 
Proposal 27/01/2020 
Revised proposal Beginning of June 2020 
Begin ethics application June 2020 
Final proposal End of June 2020 
Ethics approval (ideal scenario) Summer - Autumn 2020 
Recruitment Autumn 2020 
Data collection September 2020 - January 2021 
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Analyses and possible member 
checking 
September 2020 onwards 
Initial report draft May 2021 




Results from the interviews will be used to guide recommendations to Psychological 
services for providing psychological well-being support for people with Parkinson's 
disease, as driven by service user perspectives and preferences. A future research 
project could then investigate the efficacy of the recommendations following 
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Appendix 2.4 Consent form 
Consent Form V1.5 
Developing psychological wellbeing support for patients with Parkinson’s 
disease 
Contact details: Jessica Whyte  
Email:  
Please initial in box 
1. I confirm that I have read and understand the information sheet dated 07.01.21
(Version 1.5) for the above study.
2. I confirm that the researcher has answered any queries to my satisfaction.
3. I understand that my participation is voluntary and that I am free to withdraw from the
project at any time, without my medical care or legal rights being affected, and that
information I have provided up to that point may be included in the results of the study.
4. I understand that any information collected about me in the study will remain
confidential, and that no information which identifies me will be made publicly available.
5. I give permission to the research team to audio record my interview, and for
anonymous quotations from the interview to be used in reports.
6. I give permission for Parkinson's disease Clinical Nurse Specialists to access my
medical records to obtain information which is relevant to this study (date of birth,
gender, name of diagnosis, date of diagnosis, if I have any history of mental health
problems and if I have previously been offered support for my mental health) and pass
this information on to the research team.
7. I understand that my data (including personal information) may be accessed by
authorised representatives of University of Glasgow and NHS Ayrshire & Arran for the
purposes of audit only.
8. I would like to be informed of the results of this research by email once the study is
completed. This is an optional part of the study.
9. I consent to being a participant in this study.
10. I consent to taking part in member checks following the initial interview, and to being
contacted by the researcher about taking part in these checks. This is an optional part of
the study.
------------------------------------------               --------------------         ----------------------------------- 
Name of Participant          Date     Signature 
------------------------------------------               --------------------          ---------------------------------- 
Name of Researcher          Date      Signature 
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Appendix 2.5 Participant information sheet 
Developing psychological wellbeing support for patients with Parkinson’s 
disease 
Patient information sheet 
Version 1.5, 07/01/21 
Chief Investigator: Dr Breda Cullen, 
Clinical Psychologist 
Research Supervisors: Dr Breda 
Cullen and Dr Susan O'Connell 
Trainee Clinical Psychologist: Jessica 
Whyte 
You are being invited to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please 
take time to read the following information carefully. Talk to others about the study if 
you wish. Ask us if there is anything that is not clear or if you would like more 
information. 
What is the research about? 
This study is aiming to investigate how Psychology services can improve the support 
they offer to patients with Parkinson's disease to help improve their mental health, 
and how we can make Psychology services easier to access for people with 
Parkinson's disease. To do this, we will be interviewing people with Parkinson's 
disease over the phone or over video call. The results of the interviews will be used 
to help us improve the mental health support we offer to patients with Parkinson's 
disease in NHS Ayrshire and Arran and wider services. 
Who is being asked to take part? 
We are inviting people with a diagnosis of Idiopathic Parkinson’s Disease to take part 




Why have I been invited? 
You have been invited to take part in this research because you have a 
diagnosis of Idiopathic Parkinson’s Disease, are registered with the Parkinson's 
disease team in NHS Ayrshire & Arran, are aged 18 years or over, and may have 
reported experiencing difficulties with your mental health. 
Please return the reply slip to the researcher using the pre-addressed and pre-paid 
envelope provided if you are interested in taking part. 
If you are interested in taking part, a researcher will telephone to give you the 
opportunity to ask any questions you may have about the study and to arrange a 
time for the interview if you would like to take part.  
What will taking part involve? 
Consenting to participate in this study means that you will be asked to take part in an 
interview with a researcher, either over the telephone or over video call. During the 
interview the researcher will ask you some general questions about yourself, 
followed by questions about your experiences of support for your mental health and 
how we can improve these. In total this should take 30-45 minutes and the interview 
will be audio recorded. At the end of the interview the researcher will ask if you 
would like to take part in checks of the study results. This is an optional part of the 
study and would involve the researcher sending you a summary of the study results 
by post and contacting you at a later date to ask for your opinion on the results. 
As well as taking part in the interview, we will also request your permission for NHS 
Ayrshire & Arran Clinical Nurse Specialists to access details from your medical 
records to send to the research team at the University of Glasgow. This information 
would include your date of birth, gender, name of diagnosis, date of diagnosis, if you 
have a history of mental health problems and if you have previously been offered 
support for your mental health. 
To thank you for your time taking part in the interview you will be given a £5 
supermarket voucher. 
If at any point you are no longer able to consent during the study, you would be 
withdrawn from the study and no new data would be collected. If you have already 
taken part in an interview we may keep recordings and transcripts of your interview 
and may use these as originally agreed in the consent form. 
What are the possible benefits of taking part? 
We do not expect there to be any particular benefits to yourself by taking part. Your 
participation will help us improve the mental health support we provide for people 
with Parkinson's disease. 
132 
Are there any disadvantages or risks to taking part? 
Although we do not expect that participating in this study will cause you any distress, 
if you express distress when speaking to the researcher or through your responses 
to the interview questions, we will help you to access appropriate support if needed. 
Following the interview we will send you a post-interview sheet containing the details 
of individuals and organisations you can contact if you are feeling distressed. If you 
share information that makes the researcher concerned for your safety or the safety 
of other people, we may need to tell others involved in your care (e.g. your GP).  
Do I have to take part? 
No. It is up to you to decide whether to take part. This study is completely voluntary. 
You do not have to take part if you do not want to. 
What happens if I decide not to take part? 
Nothing. Taking part is entirely up to you. If you do not wish to take part, it will not 
affect any treatment that you currently receive and will not affect any future care you 
may need. Also, if you decide to take part, you can change your mind and withdraw 
from the study at any time, without giving a reason, and without it affecting your care 
either now or in the future.  
What will happen to my data? 
We will collect your basic personal data such as your name, contact details, date of 
birth and, limited special categories data (such as health data) in order to carry out 
the research study. We will only collect data that we need in order to conduct the 
research study. 
Legal basis for processing your data 
We must have a legal basis for processing all personal data. In this instance, the 
legal basis is a task in the public interest and consent. 
What we do with your data and who we share it with 
All the personal data in the study is processed by staff at the University of Glasgow 
and NHS Ayrshire and Arran in the United Kingdom. Appropriate security measures 
will be in place such as encryption and pseudonymisation. 
Will my information be kept confidential? 
All the information you provide will be kept confidential and the recordings and 
transcripts of your interview will only be identified by code, not your name. The 
consent forms and study data will be stored on NHS Ayrshire and Arran and 
University of Glasgow premises and will be accessible only to researchers who are 
directly involved with the research, or other authorised staff for audit purposes. 
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Electronic information will be stored on secure NHS or University of Glasgow 
computer systems. When the study has finished the transcripts from your interview 
will continue to be stored anonymously, and the recording of your interview will be 
deleted. 
If you share information that makes us concerned for your safety or the safety of 
other people, we may need to tell others involved in your care (e.g. your GP).  
The University of Glasgow is the sponsor for this study based in Scotland. We will be 
using information from you and your medical records in order to undertake this study 
and will act as the data controller for this study. This means that we are responsible 
for looking after your information and using it properly. The University of Glasgow will 
keep identifiable information about you for 10 years after the study has finished. After 
this time, data will be securely deleted. 
Your rights to access, change or move your information are limited, as we need to 
manage your information in specific ways for the research to be reliable and 
accurate. If you withdraw from the study, we will keep the information about you that 
we have already obtained. To safeguard your rights, we will use the minimum 
personally-identifiable information possible. 
You can find out more about how we use your information at 
https://www.nhsaaa.net/data-protection-notice/  
What will happen to the results of the research study? 
The results will be compiled in a report completed as part of an academic 
qualification (Doctorate in Clinical Psychology). They may later be published in a 
scientific journal and through other routes to ensure that the public are also aware of 
the findings. Some anonymised quotes from the interviews may be used in 
publications but you will not be identified in any report or publication arising from this 
study. During the interview the researcher will ask if you wish to be informed of 
results from the present study. If so, a summary of the results will be sent to you 
once the research is completed.  
Who is organising the research? 
The study is being undertaken in partial fulfilment of an academic qualification at the 
University of Glasgow and is organised by the Chief Investigator (Dr Breda Cullen) 
and research supervisor (Dr Susan O'Connell) and Trainee Clinical Psychologist 
(Jessica Whyte). 
Who has reviewed the study? 
The study has been reviewed by the University of Glasgow to ensure that it meets 
standards of scientific conduct. It has also been reviewed by an NHS Research 
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Ethics Committee, and the NHS Ayrshire and Arran Research and Development 
Department. 
What will happen if there is a problem or if I want to make a complaint? 
If you have any concerns about the study or the way it is conducted, or if you wish to 
complain about any aspect of this study, please contact Dr Breda Cullen, Mental 
Health and Wellbeing, Gartnavel Royal Hospital, Admin Building, 1st Floor, 1055 
Great Western Road, Glasgow, G12 0XH, or the Research and Development 
Department, NHS Ayrshire and Arran on 01563 825850. 
The normal NHS complaint mechanisms will also be available to you. NHS Ayrshire 
and Arran Complaints Team: 01292 513620 
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Contact for further information about the study 
Jessica Whyte Dr Breda Cullen Dr Luke Williams 
Mental Health and 
Wellbeing 
Admin Building, 1st Floor, 
Gartnavel Royal Hospital 
1055 Great Western 
Road 
Glasgow G12 0XH 
07583218206 
Mental Health and 
Wellbeing 
Admin Building, 1st Floor, 
Gartnavel Royal Hospital 
1055 Great Western 
Road 




Ayrshire Central Hospital 




Other useful contacts 
Nick Brydon & Paula Hewatt, Parkinson's 
Disease Clinical Nurse Specialists 




Parkinson's Disease UK, Ayrshire branch 
contact: Gill MacGregor 
Contact number: 0344 225 9836 
Email: vc.scotland2@parkinsons.org.uk 
Breathing Space telephone support line Contact number: 0800 83 85 87 
The Samaritans Contact number: 116 123 
Email: jo@samaritans.org 
Thank you for reading this Participant Information Sheet 
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Appendix 2.6 Invitation letter and reply slip 
Invitation letter: a research study on developing psychological wellbeing 
support for patients with Parkinson’s disease 
We are contacting you as we would like to hear your views on how Psychology 
services can best support the mental health of patients with Parkinson's disease. 
Psychology services offer support such as talking therapies to individuals who are 
having difficulties with their mental health. This support is provided by qualified 
Psychologists or other trained professionals, and is available to those who may be 
experiencing problems with their mental health, whether this is related or unrelated 
to their diagnosis of Parkinson's disease. 
In the research study we are looking for volunteers to take part in interviews with a 
researcher from the University of Glasgow. In the interview we would ask you about 
your opinions and preferences on how Psychology services can best support people 
with Parkinson's disease. The interviews will help us develop the support that 
Psychology services offer to patients with Parkinson's disease in NHS Ayrshire and 
Arran. 
The enclosed Participant Information Sheet provides more information about the 
study, and includes the contact details of the research team should you wish to 
contact them for more information about taking part. When you have read the 
information sheet, if you are interested in taking part in the study please complete 
the reply slip on page 2 of this invitation letter and send it back to the researcher 
using the pre-paid and pre-addressed envelope. The researcher will then contact 
you with further information about the study. If you are not interested in taking part in 
the study you do not need to do anything further. Thank you for taking the time to 






If you are interested in taking part in the study please tick the box 
below and send this page back using the enclosed pre-paid and pre-
addressed envelope. 
I am interested in taking part in the study and would like to be 
contacted by the researcher to discuss the study. Please note, by 
returning the reply slip you are consenting to your contact details 
being passed on to the researcher. You will only be contacted by the 
researcher if you tick "YES" below. If you decide to take part in the 
study after speaking to the researcher, we will need to record your 
consent to take part verbally during the interview. If you tick "YES" 
you will also be confirming that if you decide to take part you will be 
happy for us to record your consent verbally just before the 
interview. 
YES, I would like to be contacted by the researcher. I 
confirm that if I decide to take part I am happy for you to 
record my consent verbally and that this will be taken just 
before the interview. 
Your name ___________________________________ 
Your contact number ___________________________ 
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Appendix 2.7 Interview schedule 
Interview Schedule 
Recording: 
As you know, I need to record this interview to help me in analysing the results later. 
This interview is now being recorded. Can you confirm that is OK with you? 
RESEARCHER TO START RECORDING 
Consent: 
OK that's the recorder on now. First of all I wanted to thank you for agreeing to speak 
with me today. Can I check if you have had a chance to read over the Consent Form 
that was sent to you? What I'm going to do now is read through this with you and 
check that you consent to each of the points. 
RESEARCHER TO READ THROUGH CONSENT FORM WITH PARTICIPANT AND 
CHECK THAT PARTICIPANT CONSENTS TO EACH NUMBERED POINT ON THE 
FORM. IF PARTICIPANT CONSENTS TO TAKE PART IN THE STUDY, TICK THE 
BOX BELOW. IF NOT, DO NOT PROCEED WITH THE INTERVIEW. 
Consent given by participant 
Introduction: 
Before we begin I just wanted to thank you for agreeing to take part in the interview 
today. Your answers will help us develop the support that Psychology services offer 
to patients with Parkinson's disease in NHS Ayrshire and Arran. 
We'll start off with some quick questions about you, and then I'll ask some questions 
about your preferences and opinions on accessing support from Psychology 
services. If there are any questions you would rather not answer that is no problem 
at all, just let me know. And if at any time you would like to stop the interview or 
would like a break, just let me know and we can do this. If the call gets cut off I'll give 
you a ring back as soon as I can. Does that all sound OK? 
To start off with I'm going to ask you a few quick questions about yourself, and then 




(Adapted from Dobkin et al., 2013) 
1. What is your current marital status? 
a. Single, married, separated, divorced, widowed, living with partner? 
2. What is your employment status? 
a. Employed full time, employed part time, unemployed, retired? 
b. What is your occupation or previous occupation? 
3. What type of accommodation are you currently living in? 
a. Rented, owned, supported accommodation? 
4. To what extent do your Parkinson's disease symptoms affect your ability to 
participate in activities of daily living? 
a. Mildly, moderately, extremely? 
5. How many medical conditions are you currently diagnosed with (not including 
Parkinson's disease)? 
6. Have you ever had any concerns about your mood or wellbeing, or felt you 
needed help managing your mood or wellbeing? 
 
Thank you for answering those questions for me. In this next part I will be asking you 
questions about your preferences and opinions for Psychological support for 
wellbeing. To provide a bit of background, Psychology services offer support such as 
talking therapies to individuals who are having difficulties with their mood or 
wellbeing. This support is provided by qualified Psychologists or other trained 
professionals, and is available to those who may be experiencing problems with their 
wellbeing, whether this is related or unrelated to their diagnosis of Parkinson's 
disease. We realise you may not necessarily choose to access support from 
Psychology services yourself, but we are interested in your thoughts about the idea 
of accessing support from Psychology, or other people with Parkinson's disease 
doing this. Do you have any questions about this? 
 
Semi-structured interview: 
Interview question ideas to address research questions and using the themes from 
Todd et al. (2013) (some adapted from Krueger et al., 2001 and Letourneau et al., 
2012). Questions have been reviewed by Parkinson's disease UK. 
1.  How do you feel about accessing professional Psychological support? 
a. What makes you say this? 
b. Is there anything that would make you feel more or less comfortable 
accessing Psychological support? 
2.  How do you feel about group/individual Psychological support? 
140 
 
3. What experiences do you have of accessing psychological support? 
a. What was helpful? 
b. What was unhelpful? 
4.  If you could get one thing from Psychological support what would it be? / 
What would you most like to gain from Psychological support?  
5. What would you like to see included/addressed in Psychological support? 
a. What do you think would be helpful? 
b. What do you think would be unhelpful? 
6.  What would encourage you to participate in Psychological support? 
7.  What would prevent you / discourage you from participating in Psychological 
support? 
a. Is there anything that you think would help overcome this? 
8.  Are there any practicalities you would want us to consider when planning 
Psychological support? 
9.  What would your preferences be for the following: 
a. Mode of support (e.g. one-to-one, group, telephone, video)? 
b. Location of support? 
c. Duration of support (e.g. duration of each session and overall number 
of sessions)? 
d. Frequency of support? 
e. Time of day of support? 
10. In the future we are considering sending a letter to invite people to take part in 
psychological support. What do you think would be helpful for us to include in 
this letter? 
11. Do you have any other comments? 
 
Final question: When we have finished the interviews and have started to analyse 
the interview data, we are planning to contact some of the people who took part 
in the interviews to ask them to check the results and to give their opinions on the 
results. This is an optional addition to the study. Would you be interested in 
taking part in checking the results? If so, do you give your permission for us to 





That is the end of the interview. Thank you for taking part in the interview. We will 
send out a copy of our post-interview information sheet with details of individuals and 
organisations you can contact if you are feeling distressed in any way by the topics 
covered in the interview. Would you prefer us to send this to you by email or post? 
When the study is finished we will send out a summary of the results to everyone 
who indicated they would like this in the consent form. Would you prefer us to send 
this to you by email or post? Thank you again for your participation in the study. 
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Appendix 2.8 Samples of reflections noted in the researcher’s reflective log 
Sample 1: 05/03/21 Personal reflections following interviews with P101 & 102: 
Reflecting on the first two interviews I noticed I was incorporating my clinical skills into the 
interview with the aim of helping to make the participants feel heard, understood and 
validated. For example, I was acknowledging things that they found difficult, I was reflecting 
things back to the participants, and if the participants were struggling with words or to get 
something across, I checked in about what I had thought they meant to see if that was right.   
I’m wondering if this could be introducing biases into the results. Although qualitative 
interviews can never be completely free from bias, even the questions themselves introduce 
some bias into the answers that are given. However, I wonder if I should be doing more to try 
to minimise these biases. On the other hand, I do think that using these clinical skills helped 
to maintain the engagement of participants and allowed them to feel comfortable speaking 
openly about difficult topics. Transcription will provide a good opportunity to listen back to 
the recordings and consider this in more detail. This will help me to consider whether I need 
to adjust my approach going forwards. It is also important for me to remember that my 
theoretical stance acknowledges these biases will be present but it is important to be aware 
of them.  
I emailed my supervisor to discuss this concern. My supervisor advised that using active 
listening skills and reflecting things back to a participant is fine, if I am not talking too much 
or being too leading. 
Sample 2: 22/03/21 Reflections following the first six interviews and a meeting with the field 
supervisor:  
Participants who have had experience of mental health problems and who are able to view 
these problems as mental health problems appear to have been more readily able to reflect 
on their experiences and contribute more to the interviews, providing richer interview data. 
This is a consideration for future research focused on feedback and developing services.  
Sample 3: 16/05/21 Personal reflections on the interviews: 
• The clarifying questions asked by the researcher in every interview following the first
participant will inevitably have been influenced by all prior interviews and the
answers given by previous participants.
• A potential limitation of the study may be that participants may have held back
negative opinions of psychological services given that the researcher is part of these
services. However, some participants did provide constructive feedback and so this
may not be the case.
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Appendix 2.9 Initial framework used for indexing transcripts 
1. Attitudes towards psychological support: 
1.1. Openness to support: readiness and perceived need for support 
1.2. Impact of Parkinson’s on mental health (and life?) 
1.3. Importance of accepting help 
1.4. Positive experiences of individual support 
1.5. Negative experiences of group support 
1.6. Positive experiences of peer support 
1.7. Influence of media on perceptions of group support 
2. Barriers to accessing psychological support: 
2.1. Lack of awareness of support 
2.2. Concerns about confidentiality 
2.3. Lack of joined up services and communication between services 
2.4. Lack of awareness of symptoms and mood difficulties in Parkinson’s? 
2.5. Not feeling things are “bad” enough? 
2.6. Heterogeneity in groups: stage of disease, age, gender, preferences for approach 
2.7. Personal nature of difficulties 
2.8. Social anxiety / worry about meeting new people / discomfort with new people 
2.9. Stigma 
2.10. Attitudes of professionals 
2.11. Difficulties accessing support 
2.12. Practical barriers of location and setting 
2.13. Impact of COVID-19 
3. Adaptations to psychological support for Parkinson’s disease: 
3.1. Accessible language and breaking things down 
3.2. Providing written information 
3.3. Short sessions 
3.4. Considerations of the impact of symptoms and medication 
3.5. Support for families? 
4. Preferences for aims and content: 
4.1. Achieving a sense of wellbeing and balance? 
4.2. Adjusting to life with Parkinson’s 
4.3. Normalising mood difficulties in Parkinson’s 
4.4. Practical advice and strategies 
4.5. Rapport: Attitude/manner of the clinician 
4.6. Being realistic but not confronting 
4.7. Learning from others with Parkinson’s 
4.8. Providing choice 
4.9. Tailored to the individual 
4.10. Having a safe place to talk and be listened to 
4.11. Here and now focus 
4.12. Increasing confidence 
5. Preferences for the format of support: 
5.1. Preference for one-to-one face-to-face support 
5.2. Openness to group support – potentially later on the journey? 
5.3. Importance of similarities between group participants 
5.4. Local, accessible and comfortable location 
5.5. Fast and easy to access 
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5.6. Regular short sessions (30-60 mins) 
5.7. Time of day 
5.8. Resources 
5.9. Flexible duration 
6. Preferences for content of the invitation letter: 
6.1. Increasing awareness of support 
6.2. Providing information 




Appendix 2.10 Sample of indexing 
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Appendix 2.12 Approval email from NHS Ayrshire & Arran Psychological Services 
Business Group 
